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ABSTRACT 
- 
This thesis describes a study of the mechanisms 
involved in the elimination of established, 
morphologically identifiable electron dense deposits 
from the glomeruli of rats with chronic serum sickness. 
The initial experiments established the experimental 
model and evaluated the effects of variations in the 
method of administration, the antigen dose and charge, 
and the route of administration. The model was further 
characterized in terms of the progression of the 
morphological, functional and biochemical abnormalities 
induced. 
Methods were developed to measure the amount of 
radio-labeled antigen in isolated glomeruli, and to 
measure the volume fraction of the electron dense 
deposits in glomeruli. Study was then limited to the 
first two weeks of recovery from chronic serum sickness, 
after injections of antigen have ceased, to ascertain 
the rates at which the antigen and deposits were 
removed. 
The influence of a variety of forms of intervention 
during this recovery period was then assessed. 
Manoeuvres which increased the level of circulating 
anti-BSA antibody were found to inhibit the removal of 
antigen and deposits from glomeruli. This effect was 
confirmed by passive immunization with immune rat serum. 
Manoeuvres which increased the number or activity of 
- 
ix 
- 
glomerular macrophages had no detectable effect on the 
removal of antigen or'deposits. 
In the absence of plasma complement, the removal of 
antigen virtually ceased after four days. Cobra venom 
factor treated rats had lower proteinuria than controls, 
despite having a heavier antigen load. 
Manoeuvres which altered the, glomerular filtration 
rate and renal haemodynamics did not alter the rate of 
removal of antigen or deposits; nor did the 
administration of highly cationic molecules. The 
administration of large doses of heparin enhanced the 
rate of removal of antigen from the glomerulus, though 
an effect on deposit volume was not detected. 
-X- 
ABBREVIATIONS 
BSA Bovine serum albumin 
C3 (C4, etc. ) Third (Fourth) component of complement 
CR1 Complement receptor 1 
CVF Cobra venom factor 
FCA Freund's complete adjuvant 
FIA Freund's incomplete adjuvant 
GFR Glomerular filtration rate 
HSP Heparan sulphate proteoglycan 
Ig Immunoglobulin 
PAN Puromycin aminonucleoside 
PVA Polyvinyl alcohol 
SEM Scanning electron micrograph 
SLE Systemic lupus erythematosus 
TEM Transmission electron micrograph 
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PART ONE 
INTRODUCTION 
This thesis describes a study of the factors which 
influence the removal of immune complex deposits from 
within the glomeruli of rats with a form of chronic 
serum sickness glomerulonephritis. Glomerulonephritis in 
man is most commonly a chronic progressive disease, so 
the existence of mechanisms by which glomerular deposits 
are removed has rarely been considered. The purpose of 
this chapter is therefore to review some of the main 
forms of immune complex glomerulonephritis in man, the 
current theories of how glomerular deposits are formed, 
and, of major relevance to this thesis, the evidence 
that mechanisms exist which can remove them. This is not 
intended to be an exhaustive review but rather to select 
and emphasize those aspects of human disease which are 
of relevance to the experimental work to follow. 
Glomerular diseases in which morphologically 
identifiable immune complex deposits do not 
characteristically accumulate in the glomerulus, such as 
Goodpasture's syndrome, will not be discussed. 
The second part of this introduction will then 
describe the main forms of experimental immune complex 
glomerulonephritis which are available for study, and 
will assess the contributions which these models have 
-1- 
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made to our understanding of the pathogenesis of immune 
complex glomerulonephritis. The third chapter will 
discuss the limited experimental data available relating 
to the mechanisms by which glomerular immune complex 
deposits are altered and removed. 
The mechanisms by which immune complexes accumulate 
in the glomerulus are controversial. There are three 
main theories, which are not mutually exclusive. At the 
risk of oversimplification they may be summarized as 
follows: 
- 
1) Circulating complexes of antigen and antibody 
become trapped in the glomerulus. Such preferential 
deposition is presumably a consequence of the 
function of the glomerulus as a filter., 
2) Circulating antibodies bind to antigens, foreign or 
autologous, which have for some reason (for example 
electrical charge) become trapped within the 
glomerulus. This is commonly referred to as 'in 
situ' complex formation. 
3) Autoantibodies develop against an intrinsic 
glomerular antigen which has (or can develop) a 
discontinuous localization along the glomerular 
basement membrane. 
These theories have evolved largely as a result of 
work in experimental animals, which will be discussed 
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later. All three are capable of causing the accumulation 
of electron dense deposits, but in the absence of 
perfect animal models the exact pathogenesis of human 
glomerulonephritis can only be confirmed by studies in 
humans with that disease. Such evidence is 
circumstantial. 
The commonest form of human glomerulonephritis in 
which electron-dense deposits are found is membranous 
glomerulonephritis, a disease which bears several 
similarities to the form of experimental 
glomerulonephritis described in this work; notably the 
presence of deposits in a subepithelial location, the 
paucity of cellular proliferation and the development of 
a nephrotic syndrome. Immunofluorescence or 
immunoperoxidase studies indicate the presence of 
immunoglobulins and complement components, mainly IgG 
and C3, in a granular pattern around the capillary 
loops, correlating within the location of the electron 
dense deposits. This co-localization is the principal 
evidence in man that the electron-dense deposits which 
are identified morphologically, are actually composed of 
'immune complexes' 
- 
antibody, complement and antigen - 
though the presence in the deposits of other material, 
such as basement membrane components, has not been 
excluded. The antigen content of these deposits is 
usually unidentifiable, a problem which has considerably 
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hindered research into the aetiology and treatment of 
the condition. 
For many years the theory that membranous deposits 
accumulate by trapping of circulating immune complexes 
was unchallenged. In man, the main evidence against this 
theory is the observation that immune complexes 
frequently can not be found in the circulation, even 
using a battery of sensitive techniques. Abrass et al. 
(1980) found such complexes in 22 of 55 patients after 
exhaustive investigation. This is not the case with the 
membranous pattern of glomerulonephritis which is a 
common complication of systemic lupus erythematosus 
(SLE). The role of DNA-containing immune complexes in 
SLE nephritis has recently been reviewed by Fournie 
(1988). Circulating immune complexes are common in SLE; 
the amount correlates with the activity of the renal and 
systemic disease, and one of the defects in SLE is a 
reduced ability to clear immune complexes from the 
circulation (Frank et al. 1979). Nuclear antigens can 
often be found in the glomerulus in SLE nephritis and 
anti-DNA antibodies can be eluted (Koffler et al. 1971). 
However, the membranous pattern of glomerulonephritis in 
SLE differs from the idiopathic form in that deposits 
are also found in subendothelial and mesangial 
locations. Animal models in which trapping of 
circulating complexes is the only possible mechanism 
generally produce mesangial deposits (vide infra) and it 
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is likely that more than one mechanism is operative-in 
SLE. In the development of capillary loop deposits in 
SLE, circulating nucleoproteins,, being cationic, might 
bind to the anionic sites of the glomerular basement 
membrane, with secondary binding of antibody; indeed, 
such an affinity has been reported (Izui et al. 1976). 
The evidence supporting this theory again comes almost 
entirely from animal experiments (vide infra). 
Similarly, the suggestion that autoantibodies could be 
binding to discontinuous glomerular antigens arises from 
the similarities between human membranous 
glomerulonephritis and Heymann nephritis (Heymann et al. 
1959) in the rat, 'which is induced by immunization 
against an autologous antigen found in the proximal 
tubule brush border and on glomerular epithelial cells., 
The arguments in favour of membranous 
glomerulonephritis being an organ-specific auto-immune 
disease have been proposed by Pusey et al. (1988) as 
follows: 
- 
1) There is a strong association with HLA-DR3 (Klouda 
et al. 1979) 
2) There is an absence of features such as 
hypergammaglobulinaemia and hypocomplementaemia 
which are common in known immune complex diseases. 
3) There is an association with auto-immune diseases. 
(Pusey et al. quote Ploth et al. 1978, Horvath et 
-5- 
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al. 1979 and Jordan et al. 1981; though these are 
all single case reports of association with thyroid 
disease, and in each case the glomerular deposits 
are attributed with good evidence to thyroglobulin- 
antithyroglobulin complexes in the serum). 
- 
4) Membranous glomerulonephritis tends to recur in 
grafts (though why this makes an auto-immune 
aetiology more likely is not explained by the 
authors). 
It seems that the auto-immune theory will remain 
unproven until the responsible antigen system is 
identified in normal glomeruli. In a few cases it has 
been claimed that renal tubular epithelial antigens are 
present in glomeruli in human membranous 
glomerulonephritis (Naruse et al. 1973,1974). The 
analogy with Heymann nephritis in the rat might support 
an auto-immune etiology, but the presence of such 
antigens has been denied by others (Thorpe & Cavallo 
1980, Collins et al. 1981) 
. 
In some cases membranous 
glomerulonephritis is clearly associated with Hepatitis 
B infection, with surface and/or core antigen present in 
circulation and glomeruli (Nagy et al. 1979, Takekoshi 
et al. 1978). This would support either trapping of 
complexes or insitu formation but is conclusive for 
neither. 
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Membranous glomerulonephritis is usually a-chronic 
disease with an inexorable progression, but it is 
important to emphasize that the deposits can be removed. 
Spontaneous resolution is quite common in children 
. 
(Ramirez et al. 1982). In the terminal' stages, when the 
glomerulus is scarred beyond further use, the deposits 
become electron-lucent and disappear (Ehrenreich & Churg 
1968). Many different patterns of glomerulonephritis 
have been reported in association with neoplasia; 
membranous glomerulonephritis is the most common 
pattern; and tumour-associated antigens have' frequently 
been reported in the affected'glomeruli (Reviewed by 
Eagen & Lewis 1977, Heptinstall 1983). Successful 
excision of the tumour has occasionally been reported, 
with subsequent resorption of the deposits (Couser et 
al. 1974). In, a detailed study of patients suffering 
from cancer, but without overt'renal disease, 55% were 
found to have small amounts of IgG, C3 or electron dense 
deposits in the glomeruli (Pascal et al. 1976). 
Subepithelial deposits may also complicate syphilis 
(Yuceoglu et al. 1974), hydatid disease (Ibarrola et al. 
1981) and treatment with drugs such as penicillamine 
(Jaffe et al. 1968) captopril (Hoorntje et al. 1980) or 
gold salts (Ainsworth et al. 1981). In most cases 
successful treatment of the disease or withdrawal of the 
drug has resulted in the disappearance of the deposits, 
and in some the relevant exogenous antigen was 
demonstrated in the glomeruli. These points suggest a 
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role for an exogenous antigen in the pathogenesis of 
membranous glomerulonephritis, and serveýto emphasize 
that, although membranous glomerulonephritis is -a 
progressive disease, its progression depends on the rate 
of continuing deposition of, immune substances exceeding 
the rate of removal. Consequently, to enhance the rate 
of deposit removal is theoretically as laudable a 
therapeutic aim as to inhibit deposition. 
Acute proliferative glomerulonephritis is 
morphologically and clinically distinct from membranous 
glomerulonephritis, though subepithelial electron dense 
deposits are found in both. The disease usually follows 
an acute'streptococcal infection and typically produces 
a nephritic picture, rather than nephrotic syndrome. The 
glomeruli are swollen, almost bloodless and 
hypercellular, with an influx of neutrophils and 
mononuclear cells. Ultrastructural examination reveals 
subepithelial deposits or 'humps', which are 
characteristically larger but fewer in number than those 
seen in membranous glomerulonephritis. Smaller 
subendothelial and mesangial deposits are seen in some 
cases. It is occasionally possible, with suitable 
staining, to visualize faint concentric lines in these 
deposits, suggesting growth by accretion on the surface 
(Furness-et al. 1986). 
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The three theories of pathogenesis suggested for 
membranous glomerulonephritis may again be invoked but 
the strength of evidence for each differs. Immune 
complexes are reported to be present in the circulation 
in- most cases of active post-streptococcal 
glomerulonephritis (Border 1979, Yoshizawa et al. 1983) 
but the nature of the antigen remains undefined., Indeed, 
the presence of streptococcal antigens in the glomeruli, 
though confirmed by some (Treser et-al. 1969,1971) has 
been denied by others (Feldman et al. 1966). The finding 
of immune complexes in the-circulation does not prove 
that they are deposited in the glomerulus; they might 
dissociate or be present intermittently, and the 
possibility of 'in situ' binding of antibody to 
streptococcal antigen which is trapped in the glomerulus 
has been supported by the elution of cationic 
streptococcal antigens from affected kidneys (Vogt et 
al. 1983). Antisera from convalescent cases can be used 
to stain the glomeruli in biopsies taken early in the 
disease, 'but reactivity appears to be independent of the 
type of streptococcus involved (Treser et al. 1971). 
Finally, the possibility of a cross-reaction between 
streptococcal and intrinsic glomerular antigens has been 
reported (Fillit et al. 1985) but is not widely 
accepted, even though this would, readily explain the 
specificity of this disease as a sequel to streptococcal s 
infections. 
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The clinical course of acute proliferative 
glomerulonephritis differs markedly from that of 
membranous glomerulonephritis. Like the infection which 
precedes it, acute proliferative glomerulonephritis 
usually resolves spontaneously; the electron dense 
deposits become lucent and disappear (Tornroth 1976) 
though the glomerular damage caused in the acute phase 
may in a minority of cases result in functional renal 
impairment and progression to renal failure. It is 
tempting to suggest that the influx of cells leads to 
this more effective removal of the deposits. In addition 
to the neutrophils, macrophages infiltrate the 
mesangium. However, in uncomplicated cases none of the 
inflammatory cells are found in the urinary space, in 
the compartment in which most of the deposits are found. 
Neutrophils may be seen closely apposed to the 
glomerular basement membrane, even having replaced the 
endothelium (Furness et al. 1986) but they do not appear 
to pass through, despite the facility with which 
inflammatory cells penetrate basement membranes at other 
sites. Phagocytosis of deposits is therefore not seen 
and the case for the direct involvement of cells in the 
removal of deposits remains unproven. The influx of 
neutrophils could be an epiphenomenon to the process of 
removal; they are probably attracted by fragments of 
activated complement. Complement components co-localize 
with immunoglobulins at the site of the subepithelial 
deposits, and serum C3 is often reduced (Baldwin et al. 
- 
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1974). This Is of, relevance to the- potential of 
complement to remove immune complex deposits (vide 
infra) 
.' 
Mesangiocapillary glomerulonephritis is a 
clinically heterogeneous disease which has been divided 
into at least two groups on morphological grounds. The 
glomeruli present similar appearances on light 
microscopy, but electron microscopy reveals 
subendothelial and mesangial electron dense deposits in 
type I and a peculiar ribbon-like- accumulation of 
electron dense material within the glomerular basement 
membrane in type II. The complement system seems to be 
intimately involved; C3 is characteristically identified 
within glomeruli by immunofluorescence, often in the 
absence of immunoglobülins in type II disease, which may 
not be an immune complex glomerulonephritis (Galle & 
Mahieu 1975). 'Serum complement levels are depressed in 
70% of cases, especially in type II disease (Cameron et 
al. 1970) and the circulation often contains an 
autoantibody to the C3 convertase of the alternative 
complement pathway (C3bBb), known as C3 nephritic factor 
(Schreiber & Muller-Eberhard 1979, Whaley et al.. 1979). 
This autoantibody stabilizes C3bBb, resulting, in 
persistent complement activation. It'has been suggested 
that complement depletion might predispose to infection 
and consequent antigenmia, which' with a concurrent 
deficit in complement-mediated clearance of circulating 
- 
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immune complexes might precipitate glomerulonephritis 
(Peters & Lachmann 1974). Such a theory cannot explain 
those cases with normal complement, nor the absence of 
immunoglobulin in type II disease. The relevance of 
complement depletion is also undermined by'the finding 
that glomerulonephritis is not induced in mice made 
immunologically tolerant to cobra venom factor then 
chronically complement depleted by that agent (Simpson 
et al. 1978). 
The role of complement in disrupting circulating 
immune complexes has been extensively studied in recent 
years (Reviewed by Schifferli et al. 1986) The 
precipitation of antigen-antibody complexes, in vitro 
and in the circulation, has been shown to be due largely 
to interactions between the Fc components of the 
antibodies, rather than by extension of the Fab-antigen 
lattice (Moller 1979, Moller & Steengaard 1979). 
Activation of complement by the classical pathway leads 
to the binding of activated Cl and C3 to the FC 
component, which inhibits precipitation (Schifferli et 
al. 1980). If precipitation does occur, then activation 
of complement by the alternative pathway can also lead 
to dissolution, by disrupting the Fc-Fc bonds (Takahashi 
et al. 1978,1980; Takata et al. 1984). The formation of 
small soluble complexes might appear to be°counter-, 
productive, as experimental work has shown such' 
complexes to have the greatest nephritogenic. potential: 
- 
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(vide infra); but after fixation 
- 
of - complement the 
complexes are rapidly taken up by` binding of the 
attached C3b to the complement receptor CRI' on 
erythrocytes (primates: Siegel et al. 1981, Cornacoff et 
al. 1983) or platelets` (other species; Taylor et al. 
1985). These are then carried'to the, liver, where the 
complexes are stripped from the circulating cells and 
degraded by mononuclear phagocytes (Cornacoff et al: 
1983). CR1 also plays a role in the feedback inhibition 
of complement activation (Medof et al. 1982,1984) and 
this fascinating molecule is also found in human 
glomeruli (Gelfand et al. 1975) on the epithelial cells 
(Burkholder et al. 1977). An imbalance in this system 
clearly could have the potential to precipitate or 
exacerbate the deposition of immune complexes at sites 
such as the glomerulus. The possible involvement of 
complement in the dissolution of glomerular deposits'has 
been the'subject of relatively little study. 
Further insight into the role of complement in 
human glomerulonephritis is gained by study of inherited 
deficiencies of complement components. A partial or 
complete absence of several of the early complement 
components is associated with the development of an SLE- 
like disease, often with an immune complex 
glomerulonephritis. This has again been attributed to an 
increased incidence of infections and antigenaemia, or to 
decreased removal of circulating immune complexes. The 
- 
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latter theory is supported by the observation that 
inherited deficiencies of components after C3 (affecting 
microbial killing but not involved in immune complex 
clearance) are not associated with an increased 
incidence of SLE (Ammann & Fudenberg 1982), and by 
reports that deficiency of the complement receptor on 
human red cells (CR1) is associated with SLE (Miyakawa 
et al. 1981), though this is probably secondary to the 
SLE (Walport et al. 1985). The presence of CR1 on human 
glomerular epithelial cells was originally cited as a 
possible reason for glomerular localization of immune 
complexes (Gelfand-et al. 1975) but as the function of 
CR1 on human red cells and macrophages appears to be the 
removal of immune complexes, it seems more likely that 
there is a role for glomerular epithelial cells in the 
removal of electron dense deposits, and/or the 
inhibition of complement activity in the glomerulus. 
These possibilities do not appear to have been explored, 
probably because of the absence of CR1 on the glomerular 
epithelial-cells of experimental animals (Moran et al. 
1977) and the rapid loss of CR1 expression on human 
podocytes in culture (Ross & Medof 1985). 
Several categories of, human glomerulonephritis 
characteristically show electron dense- deposits,. which 
are confined to the mesangium. One of these, Berger's 
disease or IgA glomerulonephritis, is a common form of 
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glomerulonephritis with a characteristic clinical 
presentation of intermittent gross hwmaturia in adult 
males. It appears to be closely related to Henoch- 
Schönlein purpura. The major morphological abnormalities 
are limited to the mesangium and include increased cell 
numbers, mesangial electron dense deposits, and 
mesangial IgA and C3 on immunofluorescence, with smaller 
amount of IgG. The levels of plasma IgA, both monomeric 
and polymeric, are often increased and circulating IgA 
immune complexes are reported in many cases (Woodroffe 
et al. 1980, Stachura, et al. 1981). No consistent 
antigen has been identified but the association with IgA 
and the common development of mesangial-IgA deposits in 
chronic liver disease has led to the suggestion that 
gut-associated antigens are involved, possibly with a 
defect in the hepatic processing of gut-associated 
antigen-IgA immune complexes (Kalsi et al. 1983) 
Experimental work (vide infra) lends credence to the 
theory that deposits in a mesangial location, such as 
those which are found in Berger's disease, are most 
likely to be produced by intact circulating immune 
complexes. Berger's disease characteristically has a 
good prognosis, with exacerbations and remissions; it is, 
of interest that in one study, re-biopsy two months 
after the documentation of Berger's disease with 
numerous deposits, IgA deposits were absent (Bergstein 
1978) emphasizing again that deposits will be removed if 
deposition ceases. 
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It is evident that, the investigation of 
pathogenetic mechanisms in human immune-complex 
glomerulonephritis has been curtailed not only by 
obvious ethical limitations, but by the inability to 
identify an antigen in'the majority of cases. This may 
be due to a variety of factors. If, as seems likely, 
many different antigens can cause a single pattern of 
disease, identification will be difficult. It is likely 
that further deposition of antibody masks antigenic 
determinants, or perhaps those determinants are altered 
in some way while trapped in the glomerulus. " It is 
generally believed that only a small proportion of the 
morphologically identifiable electron dense deposits is 
actually made up of antigen. This is supported by the 
experimental" evidence to follow. 
Most of our understanding of human immune-complex 
glomerulonephritis has come through comparison with a 
variety of animal models, of variable relevance to human 
disease. These will be the subject of the next chapter. 
However, several important points are evident from the 
discussion above. Human immune complex 
glomerulonephritis is usually a chronic disease which 
involves not only the deposition but also the concurrent 
removal of antibody, complement and a variety of 
antigens within the glomerulus. Several factors can be 
identified which one might expect to influence either 
deposition or removal. The nature and amount of antigen 
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and antibody are obvious possibilities, along with the 
form in which they are presented; complexed or not, 
continuously or in pulses, etcetera. Glomerular factors 
might be important; for example the glomerular blood 
flow and filtration rate, the activities and types of 
the cells in the glomerulus and the state of the 
glomerular basement membrane, in particular its 
electrical charge. Finally, systemic factors could be 
involved: the ability of the body to effectively 
eliminate circulating antigens and immune complexes is 
likely to be particularly important. There have been 
considerable advances in recent years in our 
understanding of the factors which can influence the 
deposition of electron dense deposits in the glomeruli 
of experimental animals, but our understanding of the 
mechanisms of removal has not kept pace. These subjects 
will be discussed in the next two chapters. 
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In the absence of clearly understood pathogenetic 
mechanisms of human `disease, experimental models of 
glomerulonephritis can only be an approximation to human 
glomerulonephritis; the validity of a model can only be 
assessed by crude parameters such as its morphological 
similarity to 'a human disease. Theories derived from 
disease in animals should be confirmed in man. 
Experimental models of glomerulonephritis have produced 
almost all our evidence of'how immune complex deposits 
can develop in glomeruli, but* this can only imply how 
they do develop in man. 
The purpose of this chapter is to review the major 
animal models of immune complex glomerulonephritis 
(excluding anti-glomerular basement membrane disease) 
and to evaluate the resultant theories of how immune 
complexes may be deposited in glomeruli. The question of 
how such complexes then cause damage to the glomerulus 
will not be addressed. This chapter will provide a 
necessary preface to a discussion of our understanding 
of the mechanisms by which the deposits are removed, 
which forms the final part of this`Introduction. 
- 
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Acute serum sickness 
Experimental models 
The group of models known as serum sickness has 
contributed more data to this field than any other. 
Serum sickness was originally identified as a human 
disease, the result of the treatment of infectious 
disease with large amounts of serum from an animal which 
was immune to the relevant organism. Von Pirquet (1917) 
recognized that the disease developed as the animal 
protein was cleared from the circulation, and correctly 
suggested that it was the result of a combination of the 
foreign protein with factors elaborated by the body 
which produced a toxic substance. Hawn & Janeway (1947) 
showed that purified foreign proteins are also effective 
in producing a rabbit model of the disease. Purified 
proteins have been used almost exclusively since then, 
making the title 'serum sickness' a time-hallowed 
misnomer. Hawn & Janeway reported that pure bovine gamma 
globulin tended to produce glomerular lesions, whereas 
bovine serum albumin (BSA) tended to produce an 
arteritis. In the light of current theories of the 
importance of the anionic charge of the glomerular 
basement membrane (vide infra), this might relate to the 
greater anionic charge of BSA but nevertheless pure BSA 
has been the antigen most widely used to induce 
glomerulonephritis since that time. 
Acute serum sickness is classically induced=by, a 
single intravenous injection of a large dose (about. 
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500mg/Kg) of BSA in the rabbit. Rabbits treated thus-may 
develop an acute diffuse glomerulonephritis 10 to 14 
days later, sometimes with endocarditis and vasculitis. 
The glomeruli show diffuse uniform hypercellularity, " due 
mainly to an influx of macrophages from the circulation 
(Holdsworth et al. 1980). The, 
-lesions heal in a few 
weeks, usually with no residual deficit. 
-On the day at 
which the histological changes are most intense, 
electron dense deposits are said to be few and mainly 
subendothelial° and mesangial in location, but numerous 
subepithelial deposits develop a little later in the 
course of the disease (Fish et al. 1966). The model in 
this form is unpredictable; results vary between groups 
but typically only a third of rabbits develop 
glomerulonephritis and that is of variable severity. 
This unpredictability caused obvious problems, but it 
also provided an opportunity to study the circumstances 
under which glomerulonephritis may develop. The severity 
of the glomerular damage was found to relate to the 
animal's production of anti-BSA antibody. Animals with a 
very poor or no response produced no lesions, but more 
surprisingly animals with a very high antibody titre 
also had no disease (Germuth & Rodriguez 1973). This was 
attributed to very rapid clearance of antigen from the 
circulation in the latter group. Germuth (1953) 
described the kinetics of antigen removal in this model. 
After an initial equilibration, the level of BSA in the 
serum falls slowly for a few days. It is then rapidly 
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eliminated, presumably due to the initiation of antibody 
production, and for a day or two immune complexes are 
detectable in the circulation. These are then cleared 
and free antibody is found. Glomerular lesions develop 
only at the time of elimination of the antigen, when 
circulating immune complexes are present. Dixon et al. 
(1958) reported that antigen is not detectable in the 
glomeruli until immune complexes are present in the 
circulation. These findings led to the theory that 
intact circulating immune complexes are trapped in the 
glomeruli, a theory which precluded any alternative or 
additional suggestions for some years. 
Some further interesting studies were carried out 
by correlating the intensity, of disease with immune 
complex size. Dreesman & Germuth (1972) 
. 
reported that 
severe glomerular lesions were only found in animals 
with a fairly low antibody response, in association with 
complexes in the circulation of weight 300,000 to 
500,000 Daltons, corresponding to IgG complexes of Ag2Ab 
to Ag3Ab2. Germuth & Rodriguez (1973) claimed that small 
complexes produce severe glomerulonephritis with 
subepithelial deposits, but animals with a slightly 
better antibody response have larger complexes in the 
circulation (above 106 Daltons), which are associated 
with exclusively mesangial deposits. The importance of 
the size of circulating complexes was supported by the 
observations that serum sickness induced a high 
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molecular weight antigen (thyroglobulin: 670,000 
Daltons) produced only mesangial deposits (Germuth et 
al. 1978). 
There is a theoretical objection to a correlation 
between the nature of a glomerular disease and the 
immune complexes present in the circulation. Only a tiny 
proportion of injected antigen is deposited in the 
kidney (Wilson & Dixon 1970,1971). Complexes in the 
circulation may therefore not be representative of those 
trapped in the kidney; indeed, they may be detectable in 
the circulation because they are not being trapped in 
the tissues (McCluskey 1983). 'In the light of subsequent 
discoveries it is relevant that small immune complexes, 
which were found to be associated with severe disease, 
are also likely to be associated' with the persistence of 
free antigen in the circulation. '' 
Chronic serum sickness 
Chronic serum sickness glomerulonephritis was first 
described by McLean et al. (1951). This model is usually 
produced by daily intravenous injection of smaller 
amounts of antigen in an immune animal: typically 12.5mg 
daily in the rabbit. This produces more severe 
glomerular disease than acute serum sickness, with 
larger, more numerous electron dense deposits. The 
chronicity of the disease is closer to most forms of 
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human glomerulonephritis. This model initially suffered 
from the same lack of reproducibility as acute serum 
sickness, but Dixon et al. (1961) produced 
glomerulonephritis more consistently in the rabbit by 
matching the daily antigen dose to the amount of 
antibody produced by the animal. The success of this 
manoeuvre again emphasized the importance of- the 
antibody response and, by inference, the immune complex 
size. Unfortunately this technique is very laborious and 
animals with a very low or very high response still did 
not develop glomerulonephritis. 
Correlation of glomerular lesions with the 
properties of circulating immune complexes is open to 
even more objection in chronic serum sickness than in 
the acute form. It is to be anticipated that at the time 
of daily injection, there will be a circulating bolus of 
blood containing a considerable antigen excess. With 
mixing, the antigen will bind to circulating 
immunoglobulin and produce small immune complexes. 
Diffusion of antibody from the extravascular space and 
continuing antibody production will gradually reduce the 
antigen excess, producing larger complexes which will be 
more effectively cleared from the circulation (Mannik & 
Arend 1971). At the, 
-end of the day free antibody may 
again be found in the circulation. Thus the results of 
serum analysis for immune complexes may be; found to 
correlate better with the time of day than with the 
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glomerular lesion induced! Nevertheless it was reported 
that given a constant daily antigen. dose, animals with a 
low level of antibody production develop a membranous 
pattern of electron dense deposits with little cellular 
proliferation;, a moderate response is associated with 
severe glomerulonephritis, whereas a higher antibody 
response is associated with only mesangial deposits 
(Germuth et al. 1972,1977: Holdsworth et al. 1980). 
In the early work of Hawn & Janeway (1947) it was 
suggested that the injected antigen was trapped in the 
glomerulus, and deposits formed when circulating 
antibody bound to antigen in situ. This theory was 
subsequently discounted for reasons outlined above. 
However, the possibility that in situ complex formation 
could occur in some circumstances had not been excluded. 
The evidence cited above indicates strongly that large 
(but soluble) complexes can be trapped in the mesangium 
and create deposits there. This is not surprising as 
plasma macromolecules are known to pass through the 
mesangium in the normal state (Takamiya et al. 1979, 
Latta & Fligiel 1985). But how can large complexes pass 
intact through the glomerular basement membrane? It was 
perhaps not fully appreciated at the time, but in the 
circumstances described above in which subepithelial 
deposits were found, it was usually the case that free 
antigen was either known or was likely to be present in 
the circulation. This raises the possibility of in situ 
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formation'-as'-'a mode of development of subepithelial 
deposits. Early evidence that antigens could be trapped 
in the glomerulus, at least in the mesangium, in the 
absence of antibody was provided by Mauer et al. (1973), 
who gave intravenous injections of heat-aggregated human 
IgG. The subsequent administration of antibody against 
human IgG produced glomerular lesions. The validity of 
this alternative mechanism was supported by the findings 
of Steward (1979). He induced chronic serum sickness 
glomerulonephritis in two strains of mice, selected for 
their tendency to produce either high avidity or low 
avidity antibodies to protein antigens. The former, 
whose immune complexes would not be expected to 
dissociate in the circulation, formed mesangial 
deposits. The latter, whose complexes tended to 
dissociate, formed subepithelial deposits. Further 
evidence of the importance of local dissociation of 
complexes was provided by Iskandar and Jennette (1983), 
who induced chronic serum sickness glomerulonephritis in 
mice, and found that animals producing predominantly 
mesangial deposits had circulating antibodies of high 
avidity, but the'development of subepithelial deposits 
was associated-with low avidity antibodies. 
" << 
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Passive serum sickness 
The serological complexity of acute and chronic 
serum sickness models made it difficult to resolve the 
situations in which trapping of immune complexes or in 
situ aggregation was occurring. This problem was partly 
solved by the development of passive serum sickness 
models of glomerulonephritis, in which lesions are 
induced by the infusion of immune complexes (or their 
components) into the circulation (McCluskey & Benacerraf 
1959, McCluskey et al. 1960,1962) 
. 
This can cause 
deposits to form within hours, too rapidly for the 
animal's own immune system to be activated. Such 
infusions still invariably contain complexes of various 
sizes and the possibilities of alteration in the 
circulation and selective deposition of a small sub- 
group still persist, but the situation is undeniably 
better controlled than in active forms of serum 
sickness. 
Large insoluble complexes do not cause 
glomerulonephritis unless they are infused directly into 
the arterial system (Gabbiani et al. 1975, Shigematsu et 
al. 1979), when they cause a focal segmental 
proliferative glomerulonephritis with deposits confined 
to the capillary loop and mesangium. This pattern is 
probably analogous to that produced by subacute 
bacterial endocarditis. This is presumably because large 
complexes are effectively removed in the lungs, liver 
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and spleen. Very small complexes (in considerable 
antigen excess) are not trapped at all, but persist in 
the circulation (Mannik & Arend 1971). Infusion' of 
fairly small soluble complexes usually produces 
mesangial. deposits, but studies which paralleled that of 
Steward described above showed that infused complexes 
formed with high avidity antibodies tend to°localize in 
the mesangium (Germuth et al. 1979a) but complexes 
formed with low avidity antibodies can form 
subepithelial deposits (Germuth et al. 1979b; Koyama et 
al. 1978). -This finding has more recently-been confirmed 
using monoclonal antibodies of carefully defined 
characteristics, thus avoiding the problem of antibody 
heterogeneity (Lew et al. 1984). The possibility that 
subepithelial deposits form by disaggregation and in 
situ re-aggregation in the glomerulus is again implied; 
indeed, it has been suggested that spontaneous 
glomerulonephritis occurs when the increase in, antibody 
affinity normally seen with progression of, an immune 
response does not occur (Devey et al. 1984). 
Variations of the passive serum sickness model are 
well suited to test the validity of in situ immune 
complex formation. Sequential perfusion of the kidney 
with antigen followed by antibody, without mixing, was 
shown to be capable of producing subepithelial deposits, 
particularly if the antigen concerned has some affinity 
which leads it to bind to the glomerular capillary wall. 
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Golbus and Wilson (1979) gave concanavalin A as an 
infusion to one renal artery. This lectin binds to 
saccharide`'components of the glomerular capillary. 
Subsequent systemic administration of anti-concanavalin 
A antibody induced glomerulonephritis in the perfused 
kidney only, eliminating the possibility of involvement 
of -, circulating immune complexes. " Other investigators 
have since produced similar results using a variety of 
antigens (Batsford et al. 1980, Adler et al. 1983a), 
usually producing subepithelial deposits. This confirms 
that in-situ formation can occur, 'and the contrast with 
other forms of passive serum sickness supports the view 
that this is at, least a possible mechanism by which 
subepithelial deposits may form. However, immune complex 
trapping and in situ formation' are not mutually 
exclusive. They could occur simultaneously and even 
where whole complexes are trapped in the mesangium there 
is evidence that dissociation and rearrangement are 
essential for persistence, as complexes which were 
covalently bound together were rapidly removed (Mannik 
et al. 1983). This rearrangement may be dependent upon 
the presence of plasma complement (Sawtell et al. 1988). 
The amount and avidity of the antibody have thus 
been shown to influence the pattern and severityýof'the 
glomerular lesions in serum sickness, but other 
properties of the antibodies have -- received -less 
attention. Pincus et al. (1968) suggested-that 
-non- 
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precipitating antibodies produced a worse 
glomerulonephritis than precipitating antibodies, 
presumably because they are cleared from the circulation 
more slowly: though the large size of'precipitating IgM 
antibody might also inhibit subepithelial deposition 
(Dreesman & Germuth 1972). Haakenstad (1976) showed that 
immune complexes prepared with reduced and alkylated 
antibodies accumulate more in, glomeruli and persist 
longer than complexes formed with untreated antibodies. 
Such altered antibody does not interact normally with 
complement or Fc receptors on phagocytes, factors which 
are likely to cause persistence in the circulation. It 
has since been shown that the aggregation of immune 
complexes occurs at least partly through interaction of 
the Fc components of the antibodies (Moller & Steengaard 
1979), rather than by formation of a-. lattice with 
antigen and Fab, so the degree of aggregation of the 
complexes may also have been altered in-a way which the 
author was not able to assess. 
The influence of antibody class has received little 
attention, though it has been reported that 
glomerulonephritis in man where the only immunoglobulin 
class present is IgM is associated with deposits in an 
exclusively mesangial location (Cohen et al. 1978, 
Lawler et al. 1980, Hsu et al. 1984), and it was 
suggested that the large molecular weight of IgM was the 
cause of this pattern of localization. Similarly,. the 
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characteristic nature' of Berger's disease in -man 
indicates that antibody class might be important; one 
may suggest here that the ability of IgA to adopt a 
polymeric form might predispose to the., development of 
large complexes and hence the observed mesangial 
deposits. Models of IgA disease have been described; 
Rifani et al. (1979) inoculated mice with a myeloma cell 
line which produced an IgA antibody against 
dinitrophenol (DNP). Subsequent administration of BSA 
linked the DNP produced mesangial deposits alone. 
Passive serum sickness- using the same monoclonal 
antibody also produced mesangial deposits, but" only if 
polymeric IgA was used. Monomeric IgA complexes did not 
cause glomerular deposition. Isaacs et al. (1981) used 
neutral dextrans to induce chronic serum sickness. This 
antigen elicits a predominantly IgA response, and only 
mesangial deposits were produced; but here it is unclear 
whether it is the nature of the antibody or the large 
size of the antigen which causes this localization. In a 
recent experiment hybridoma technology was used to 
create two monoclonal antibodies with identical binding 
sites but different heavy chain types (IgE and IgG2) 
. 
Passive serum sickness was induced in mice using these 
antibodies and no differences could be discerned in the 
pattern or intensity of glomerular damage induced (Chen 
et al. 1987) Given the intimate involvement of the 
complement system in the handling of immune complexes in 
the circulation and in the glomerulus, one might perhaps 
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expect that the ability of an antibody to activate 
complement might have profound effects on the 
localization and-fate within the glomerulus; IgA, D, E 
and G4 do, not activate complement. Regrettably, with 
regard to the work of Chen et al. described above, IgG2 
only fixes complement-weakly. This-aspect of complement 
class does not appear to have been studied further. 
It is-apparent that the nature and quantity-of both 
antigen and-antibody have a profound influence on the 
extent to which deposition in the glomerulus will occur. 
However, the characteristics of the host are also 
important in this respect. 
Hamodynamics 
The fact that the glomerulus is a high pressure 
ultrafiltration system may be assumed to contribute to 
the trapping of immune complexes (Germuth et al. 1967). 
It has been demonstrated that hmmodynamic factors can 
influence the localization of complexes in glomeruli. 
Stenosis of the artery to one kidney inhibits the 
subsequent development of immune complex 
glomerulonephritis in that kidney in experimental 
animals (Germuth et al. 1967) and in man (Salyer & 
Salyer 1974). Benacerraf et al. (1959) first showed that 
J 
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the injection of vasoactive amines can enhance the 
glomerular accumulation of colloidal carbon. Conversely, 
antagonists of serotonin and histamine decrease the 
severity of acute serum sickness glomerulonephritis in 
the rabbit (Kniker & Cochrane 1968). The injection of 
preformed immune complexes with colloidal carbon was 
also shown to enhance glomerular localization of the 
carbon (Benacerraf et al. 1959), providing the 
interesting suggestion that- immune complexes might 
produce haemodynamic effects which enhance their own 
localization in the glomerulus. Camussi et al. (1982) 
have provided some experimental evidence that immune 
complexes in the circulation can produce hmmodynamic 
effects by causing release of platelet activating factor 
from basophils; this in turn causes the release of 
vasoactive amines from platelets. It is reasonable to 
suggest that alterations in glomerular haemodynamics 
might also be responsible for the increased glomerular 
trapping of immune complexes which has been reported 
when the glomerulus already contains immune complex 
deposits (Ford & Kosathka 1980). 
Other properties of the normal glomerulus may, 
contribute to the trapping of circulating complexes or 
free antigen. The most important of these appears to be 
electrical charge (Gallo et al. 1982). 
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The observation that the glomerular filter °is 
selective on the basis of molecular, charge as well as 
molecular size was first reported by'Bohrer et al. 
(1978), on the basis of studies of the glomerular 
rejection coefficients of various macromolecules 
including dextrans of similar molecular weight but 
different isoelectric point (PI). Cationic 
macromolecules were found to reach the urinary space 
much more readily than anionic ones. 'Anionic sites' 
were subsequently demonstrated on the laminae rarae of 
the glomerular basement membrane and on the plasma 
membranes of the epithelial cells by several groups, by 
the use of cationic dyes such as polyethyleneimine 
(Schurer et al. 1978), Alcian blue (Caulfield 1979) and 
colloidal iron (Hirsch et al. 1981). Digestion with 
selective enzymes suggested that the anionic charge of 
the epithelial cells is created predominantly by sialic 
acid residues (Quatacker et al. 1985), whereas that on 
the basement membrane is created by the presence of 
heparan sulphate proteoglycan (HSP), as it is abolished 
by heparitinase (Kanwar et al. 1980, Rosenzweig & Kanwar 
1982, Kanwar 1984). Biochemical analysis of isolated 
glomerular basement membranes indicates that carboxyl 
groups are much more numerous than the sulphate groups 
of HSP but perhaps the localization of the latter 
renders its charge more functionally important. 
Yýý iýcF 
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There has been much, speculation and conflicting 
evidence over the importance of these charged layers in 
maintaining normal glomerular filtration; and over 
whether the charge is-lost in human glomerular disease. 
A discussion, of these controversies is outside the scope 
of this thesis, but the evidence that the glomerular 
anionic charge can influence the localization of antigen 
will be reviewed. 
Border et al. (1982) studied the chronic BSA serum 
sickness model of glomerulonephritis in the rabbit. 
Using native BSA under the conditions of their 
experiments, the animals developed mainly mesangial 
deposits. The antigen was then modified by the covalent 
linkage of ethylenediamine by the method of Hoare and 
Koshland (1967), altering the pI of the BSA from 4.6 
(anionic) to above 9 (cationic). Animals receiving this 
antigen under otherwise identical conditions rapidly 
developed subepithelial deposits. (In a similar 
experiment in the rat, the same group had previously 
reported deposit localization reversed from that 
described above for the rabbit; native BSA produced 
mesangial deposits and cationic BSA produced 
subepithelial accumulation (Border, eet 4 al. 1981) ., This 
report has not been confirmed and, the anomaly remains 
unexplained). No differences could be detected- inthe 
immune responses of the animals or in, 
-the circulating 
immune complex load, so, - it was assumed`-that : the 
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difference was caused by Attraction between the anionic 
basement membrane and the cationic antigen. This was 
supported by the finding that simultaneous 
administration of protamine (another cation) with the 
cationic BSA decreased the numbers of subepithelial 
deposits and the proteinuria in-this model (Adler et al. 
1983b). It was assumed that this was due to 
neutralization of the glomerular anionic charge by the 
protamine. The possibility that. the protamine might have 
this effect through hmmodynamic alterations was not 
adequately excluded but this seems unlikely as 
polyethyleneimine (which is also cationic) was reported 
to enhance the deposition in the glomerular capillary 
wall of pre-formed immune complexes containing native 
BSA (Barnes & Venkatachalam 1984). The pI of these 
complexes was not measured but it is not likely that 
they were cationic. 
These experiments did not prove whether it is 
cationic complexes or free cationic antigen which 
initially binds to the glomerular anionic sites but it 
is tempting to suggest that the subepithelial 
localization is the result of binding of free antigen, 
with secondary attachment of antibody and in situ immune 
complex formation. Adler et al. (1983b) showed that this 
mechanism is at least a possibility; they gave cationic 
BSA to non-immune rabbits, then removed the kidneys and 
perfused them in vitro with sheep anti-BSA serum. 
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Capillary wall deposits of IgG and C3 were formed. 
-There 
appear to be efficient mechanisms for the removal of 
cationic substances from the glomerular basement 
membrane if antibody is not present; Gauthier et al. 
(1984) reported initial rapid glomerular localization of 
cationic antigen but complete removal within 12 hours in 
non-immune animals. However,, the events following 
binding of antigen in the glomerulus of an immune animal 
are probably, quite complex. ; Vogt et al. (1982) 
suggested, on the basis of careful sequential electron 
microscopic studies, that complexes may form first in 
the subendothelial space,, but then move (presumably by 
dissociation and re-aggregation) to the subepithelial 
space. This suggestion has been supported by a recent 
report which suggests that transport of complexes across 
the basement membrane may be complement dependent. 
Sawtell et al. (1988) reported that mice given 
cationized bovine gamma globulin would develop 
subepithelial deposits only if complement was present; 
after depletion of C3 with cobra venom factor only 
subepithelial deposits formed. A related but C5 
deficient strain could form subepithelial deposits, 
indicating that, as with immune complex disaggregation 
in vitro, the later complement components are not 
required. 
The electrical charge of the antibody is also 
likely to affect glomerular localization (Feintzeig et 
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al. 1986). Cationic antibodies appear to gain more ready 
access to- the subepithelial 
- 
space than anionic 
antibodies'(Mädaio et al. 1984), -and anti-DNA antibodies 
eluted from the kidneys of mice suffering from 'a model 
of SLE glomerulonephritis were found to be more cationic 
than those in the circulation _(Ebling & Hahn 1980). 
Gauthier et al. (1984) reported that immune complexes 
prepared with anionic antibodies tended to produce 
mesangial deposits, whereas complexes containing 
cationized' antibodies localized' initially in the 
subendothelial space, with subsequent transfer to the 
subepithelial location (Gauthier et al. 1982). 
The effect `of 'charge is clearly of great interest 
but its importance, is not exclusive; although some form 
of in situ aggregation is probably always involved in 
the formation of subepithelial deposits, the antigen 
does not'have to be cationic. " Fleuren et al. (1980) 
perfused the isolated rat kidney alternately with'native 
(anionic) BSA and anti-BSA. This produced subepithelial 
deposits, whereas pre-formed BSA-anti-BSA complexes in 
the same preparation did not. Furthermore, if the 
antigen is very -large it may be excluded from the 
subepithelial space despite bearing a cationic charge. 
(Vogt et al. 1982). Other factors may cause-an antigen 
to bind to the glomerular wall; the example "of 
concanavalin A has been mentioned above and DNAhas-been 
found to have an affinity for and bind"to-the glomerular 
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basement membrane, an observation of great potential 
significance to the nephritis of SLE (Izui et al. 1976). 
Finally, it should be borne in mind that the relevance 
of antigen charge has not been shown in man, with the 
possible exception of cationic streptococcal antigens 
and acute proliferative glomerulonephritis (Vogt et-al. 
1983). r [.,. 
Circulating antigen/antibody levels 
It has ben stressed above that the ratio of antigen 
to antibody in the circulation was found to be an 
important factor in the development of immune complex 
glomerulonephritis; but in addition it is reasonable to 
assume that the glomerular deposition of circulating 
immune complexes or antigen will be related in some way 
to the overall amount of the complexes or antigen in the 
circulation. The rate of elimination of such substances 
from the circulation is therefore likely to be 
important. In normal circumstances the formation of 
circulating immune complexes can be seen as a protective 
mechanism, as it leads to the rapid elimination of the 
antigen concerned; the involvement of complement in the 
clearance of immune complexes was outlined in the 
previous chapter. 
-It has already been noted that large 
complexes formed in antibody excess are rapidly cleared 
and are not nephritogenic (McCluskey et al. 1962,, Mannik 
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& , Arend 1971). If the efficiency of this clearance'is 
impaired, 
-the complexes might persist in the circulation 
and accumulate in the glomeruli. -Some evidence that this 
effect might be important in man has already been 
discussed, in relation to the increased incidence of SLE 
and glomerulonephritis incases of inherited deficiency 
of complement components. In experimental animals the 
presence of large quantities of circulating immune 
complexes seems to saturate the antigen clearance 
system, decrease the rate of elimination and increase 
glomerular localization (Haakenstad & Mannik, 1974, 
Bourne et al. 1983). This was attributed to blockage of 
macrophage function but depletion of complement and 
complement receptors 'could also have played a role. 
Conversely, stimulation of the phagocytes by inoculation 
with Corynebacterium parvum 
-increases the uptake and 
degradation of complexes by the mononuclear phagocyte 
system and decreases glomerular localization (Barcelli 
et al. 1981), a finding of direct relevance to this 
thesis. 
Heymann nephritis 
It has been shown that immune complexes can be 
deposited in glomeruli by trapping of circulating 
complexes or by assembly in situ, after an antigen has 
been trapped in the glomerulus, or a combination of 
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both, with dissolution and re-assembly in another 
(subepithelial) site. It was thought until recently that 
the presence of auto-antibodies against components of 
the glomerular capillary wall could not give rise to 
morphologically identifiable electron dense deposits, 
but would instead produce a 'linear' pattern of 
immunoglobulin deposition, as demonstrated by 
immunofluorescence. Studies of the form of auto-immune 
glomerulonephritis in rats known as Heymann nephritis 
(Heymann et al. 1959) have now shown this view to be 
false and have established a third mechanism by which 
glomerular immune complex deposits can form. In Heymann 
nephritis, administration of homologous kidney 
homogenate in Freund's complete adjuvant produces a 
nephrotic syndrome and chronic glomerulonephritis with a 
striking morphological similarity to human membranous 
glomerulonephritis (Alousi et al. 1969) 
. 
It was 
subsequently shown that the same disease can be induced 
by immunization with microgram amounts of a fraction of 
renal tubules known as Fx1A (Edgington et al. 1968, 
Glassock et al. 1968). The antigen has been 
characterized as a glycoprotein of molecular weight 
j 1, 
330,000 (gp330) which is localized in the brush border 
of the proximal tubules (Keraschki & Farquhar 1983, 
Makker & Singh 1984). Similar deposits can be produced 
by transfer of serum from diseased rats (Sugisaki et al. 
1973) or immune rabbits (Barabas & Lannigan 1974); the 
latter is known as heterologous Heymann nephritis, as 
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the most severe glomerular damage results from the 
development of immunity against the foreign antibody 
deposited in the glomerulus. 
The amount of antigen given at immunization is so 
small that any directly produced circulating immune 
complexes would be present in insufficient quantity to 
produce disease. Consequently it was initially thought, 
by analogy with the concepts of serum sickness current 
at that time, that the disease was due to the formation 
of circulating immune complexes with the trace amounts 
of gp330 normally present in the circulation (Glassock 
et al. 1968, Singh & Makker 1985). Initial evidence that 
this was not necessarily the case came first from in 
vitro perfusion experiments (Couser et al. 1978). 
Antibody against Fx1A, from immune rabbits or eluted 
from diseased rat kidneys, was shown to produce 
subepithelial deposits in the absence of any external 
antigen. Furthermore, antibody from diseased kidneys was 
found to bind to sections of normal rat glomeruli, 
indicating the constitutive presence of the appropriate 
antigen (Neale & Wilson 1982). Glomerular reactivity was 
eliminated by prior adsorbtion with FxlA. More recent 
studies indicate that antibody binds to gp330 which is 
localized in coated pits on the glomerular epithelial 
cells, but instead of producing antigen elimination or a 
linear pattern of deposition, relocation and aggregation 
takes place, leading to the formation of subepithelial 
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deposits (Kerjaschki & Farquhar 1983, Camussi et al. 
1985, Cybulski et-al. 1988). There is thus good evidence 
that antibodies against FxlA can produce immune-complex 
deposits, which are indistinguishable by electron 
microscopy or immunohistochemistry from those produced 
by other means. It is possible that a mechanism 
analogous to this produces membranous glomerulonephritis 
in man 
- 
some authors refer to the model as 
'experimental membranous glomerulonephritis' 
- 
but there 
is no direct supporting evidence. Indeed, Heymann 
nephritis has not been adequately duplicated in any 
other species, and Collins et al. (1981) were unable to 
detect a comparable tubular antigen in human glomeruli, 
whether normal or affected by membranous 
glomerulonephritis. The main factor controlling the 
formation of immune complex deposits by this mechanism 
is the maintenance of immunological tolerance; this is 
outside the scope of this thesis and has recently been 
discussed in this context by Pusey et al. (1988). 
Many other models of immune complex 
glomerulonephritis have been described but although they 
have contributed valuable information to the field in 
general, no other basic mechanisms of immune complex 
deposition have been demonstrated beyond the three 
outlined above; the trapping of circulating immune 
complexes, the formation of immune complexes in situ 
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after trapping of antigen in the glomerulus, and the 
formation of complexes after binding of antibody to a 
normal component of the glomerulus. It is appropriate to 
stress again that glomerulonephritis is usually a 
chronic disease and the deposition of immune complexes, 
by whatever mechanism, is only the first of a complex 
sequence of events. Deposits in the glomerulus may be 
modified, made more stable or removed, even as fresh 
deposition continues. These processes will be discussed 
in the next chapter. 
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Much of the 
- 
experimental work relating to the 
deposition of immune complexes in the glomerulus has 
utilized acute animal models, where the nature and 
distribution of the complexes are studied almost as soon 
as they form. This approach successfully limits the 
possibility of confusion due to alteration of the 
deposits. after they form, but the specific study of the 
nature and effects of such alterations has consequently 
been neglected. It has been emphasized that human 
glomerulonephritis is usually a chronic disease and 
therefore such alterations are likely to be of 
importance; indeed it Is theoretically possible that 
enhancement of the removal of immune complexes could be 
as valuable a therapeutic. manoeuvre as inhibition of 
deposition. The purpose of this chapter is to examine 
the evidence that immune complexes are modified after 
deposition in the glomerulus, and the theories of how 
modification and removal might occur. 
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Evidence for the modification of deposits 
Much of the evidence that the deposits seen in 
human glomerulonephritis can be modified over time has 
already been discussed. It has long been evident that 
the electron dense deposits seen in long-standing immune 
complex glomerulonephritis differ in their morphology 
and content from those found in more acute forms of the 
disease. Ehrenreich & Churg (1968) described the 
morphological alterations in human membranous 
glomerulonephritis; the deposits become surrounded by 
what appears to be basement membrane matrix, and as the 
glomerulus becomes non-functional, the deposits become 
electron-lucent. Similar changes can be seen in chronic 
animal models such as murine SLE. These changes occur 
over weeks or months, but modification of immune. complex 
deposits also occurs much more-rapidly-than this. As has 
been stressed in the previous chapter, cationic immune 
complexes and antigens can bind to the glomerular 
anionic sites. Such immune complexes can-be displaced 
from the glomerulus if another cation is administered 
within a few minutes, but by one hour a change has 
occurred such that removal is no longer possible by this 
method (Gauthier & Mannik 1986). In chronic serum 
sickness, alteration of the location of deposits has 
been reported during the early course of the disease 
(Vogt et al. 1982) but although the authors suggested 
that this was due to dissolution and re-localization of 
- 
45 
- 
Chapter 3 Immune complex removal 
the same molecules, the possibility that further 
deposition of new complexes was, responsible was not 
excluded. 
The importance of re-equilibration of immune 
complexes after deposition was demonstrated more 
convincingly by Mannik et al. (1983). They developed a 
passive model of serum sickness using an antigen which 
could be induced (by irradiation with light) to form 
covalent bonds to the complexed antibody, thus 
precluding any possibility of further rearrangement. 
Covalent and non-covalent complexes accumulated in the 
mesangium in similar amounts at 1 hour, but subsequently 
only the non-covalently linked complexes persisted. The 
conclusion, that rearrangement of immune complexes is 
necessary for persistence, illustrates the importance of 
processes which occur after-the initial deposition (As 
was noted in the previous chapter, this work is also of 
significance to the- argument about the relative 
importance of trapping of circulating complexes versus 
'in situ' formation). 
There is further direct evidence that the 
composition of immune complexes changes with time; 
rheumatoid factors have been found both in the serum and 
in glomerular deposits in chronic serum sickness (Penner 
et al. 1979) and in long-standing human 
glomerulonephritis, where the presence of anti-globulins 
may indicate a worse prognosis (Rossen et al. 1975). 
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More recently, globulin/antiglobulin complexes in serum 
and glomeruli have been shown to represent 
idiotype/anti-idiotype antibodies (Zanetti & Wilson 
1983), as might be expected from current theories of 
regulation of the immune system (Jerne 1975). Free 
antibody and even immune complexes of the same antigen 
system can bind to deposits already present in glomeruli 
(Ford & Kosatka 1980), which supports the widespread 
view that the deposits grow by a process of 'molecular 
accretion' (Pusey et al. 1988). 
Finally, apparently, unrelated substances such as 
horseradish peroxidase and catalase (both small 
macromolecules) can accumulate within established 
deposits in Heymann nephritis (Schneeberger et al. 1974, 
1979). No explanation of this phenomenon was proposed 
other than passive trapping. Given the stimulus which 
immune deposits appear to provide to the synthesis of 
basement membrane material by epithelial and mesangial 
cells in some forms of chronic glomerulonephritis, it 
would also seem likely that with time, intrinsic 
basement membrane components such as type IV collagen 
could become enmeshed in the deposits. This might confer 
increased stability but such an event has not been 
experimentally confirmed. 
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Removal by phagocytosis 
Immune complex removal 
There is in normal glomeruli a continuous flow of 
plasma through the mesangium (Takamiya et al. 1979, 
Latta & Fligiel 1985). It has been known for many years 
that apparently inert particles such as colloidal carbon 
and ferritin can become trapped in the glomerular 
mesangium (Farquhar & Palade 1961, Elema et al. 1976). 
The particles may emerge at the vascular pole (Elema et 
al. 1976, Michael et al. 1979) and leave via the distal 
tubules, the efferent arteriole or the lymphatics, but 
such particles can frequently also be seen within the 
cytoplasm of cells in the mesangium, presumably having 
been phagocytosed. The cells involved were initially 
assumed to be the intrinsic mesangial cells, and this 
may indeed be the case with some substances (Sterzel et 
al. 1982, Mancilla-Jimenez et al. 1982) but the 
discovery that glomeruli normally contain a sub- 
population of macrophage-like cells (Schreiner et al. 
1981, Schreiner & Unanue 1984) which are recruited from 
blood monocytes (Gurner et al. 1986) has led to a re- 
appraisal. Numerous studies have assessed the importance 
of these glomerular phagocytes in the trapping and 
processing of a variety of materials which accumulate in 
the mesangium (Sterzel et al. 1982, Goode et al. 1985, 
Sedor et al. 1987). The effect of polyvinyl alcohol 
(PVA) has been much studied in this context. Repeated 
injections of this inert pclymer cause accumulation of 
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PVA in the mesangium. It is found to be inside the 
phagocytic vacuoles of Ia 'positive mesangial 
macrophages, which are increased in number and activity, 
although glomerular haemodynamics appear to be almost 
unaltered (Sterzel et al. 1983, ' Seiler- et' al. 1983) 
. 
Such treatment 'causes, increased 'accumulation of 
colloidal carbon (Mauer et al. 1979) 'and iron dextran 
(Seiler" 'et al. 1986) ; in the latter example the PVA- 
induced macrophages processed the iron, dextran to 
ferritin-more rapidly than controls. These findings with 
particulate tracers would appear to be of relevance to 
the mesangial processing of immune` complexes. -Striker et 
al. (1979) showed that mesangial macrophages are 
involved in the-phagocytosis and degradation of immune 
complexes in a passive serum sickness model. In this 
important work, the mice studied had received bone 
marrow transplants from Chediak-Higashi mice, whose 
phagocytic cells'have recognizable giant lysosomes; this 
allowed reliable confirmation' that the- intrinsic 
mesangial cells were not involved. 'Batsford et al. 
(1985) have studied some of the characteristics of the 
antigen which influence the uptake and processing by 
mesangial macrophages: cationic charge and 'biologic 
activity' ('increased' by covalent attachment of 
glutaraldehyde to the- antigen) were found to enhance 
uptake and removal. 
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It is thus reasonably well established that 
mesangial macrophages are involved in the uptake and 
processing of material, presumably including immune 
complexes, as it arrives in the mesangium and soon 
after. But what of the capillary loop deposits, to which 
macrophages do not have ready access? Even in the 
mesangium, is a mechanism which deals with immune 
complexes as they arrive in the glomerulus necessarily 
involved in the processing or removal of established, 
morphologically identifiable deposits, which are 
unlikely to have the same content or structure as 
circulating immune complexes? Mesangial deposits are 
capable of persisting for some time without further 
deposition of the original antibody/antigen system, and 
although Striker et al. (1979) described material 
morphologically resembling electron dense deposits 
within phagocytic vacuoles, this was seen within hours 
of administering pre-formed immune complexes. 
Phagocytosis of electron dense deposits has been assumed 
to occur later than this: in the NZB/NZW model of SLE in 
the mouse, Kimura et al. (1987) commented that 
mononuclear phagocytes are "presumably contributing to 
the scavenging of the mesangium" and observed that 
"mononuclear cells, extending their cytoplasmic 
protrusions towards the dense (immune complex) deposits, 
were frequently noticed". Phagocytosis of established 
electron dense deposits does not appear to have been 
observed. It is of interest in this context to note the 
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effect of a modification in the number of glomerular 
TMacrophages on the course- of experim. ntal 
glomerulonephritis. Lavelle et al. (1981) gave anti- 
macrophage serum to rabbits with acute serum sickness at 
the point of immune' elimination of the antigen from the 
circulation (i. e. the time of glomerular deposition). 
The amount of glomerular damage and proteinuria was 
reduced, confirming the importance of macrophages in the 
development of glomerular injury in this model. If 
macrophages are involved in the degradation of immune 
complexes, one would expect treated animals to have 
heavier deposits in their glomeruli. The reverse was 
reported. The authors suggest that this was due to "the 
absence of the deleterious effect of macrophage 
enzymes". These results are confirmed by Holdsworth et 
al. (1981), but again the authors ignore the inference 
that macrophages are not removing the deposits. 
Furthermore, pre-existing mesangial complexes, which 
might be expected to enhance phagocytic function if this 
system is involved, are reported to cause a decrease the 
efficiency of removal (Keane & Raij 1980). Boyce & 
Holdsworth (1986) showed that administration of anti- 
macrophage serum reduced the subsequent glomerular 
trapping of heat-aggregated IgG: conversely, they also 
observed that in glomeruli with an increased number of 
macrophages due to anti-basement membrane 
glomerulonephritis, the mesangial uptake of heat- 
aggregated IgG was greater than in controls (Boyce & 
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Holdsworth 1986). Similarly, in nephrotic syndrome 
induced by puromycin aminonucleoside, the mesangial 
uptake of heat-aggregated IgG was increased (Keane & 
Raij 1985). This increase is probably caused by altered 
glomerular haemodynamics, as it was blocked by infusion 
of an inhibitor of Angiotensin II, but it is remarkable 
that in none of these studies was the expected inverse 
correlation between glomerular-macrophage numbers and 
mesangial deposits reported. This implies that the 
presence and activity of macrophages in the glomerulus 
does not enhance deposit removal. 
If, despite the above evidence, macrophages do 
degrade established glomerular immune complex deposits, 
then it is likely that the proteolytic enzymes they 
contain will be utilized. The importance of such enzymes 
is given some support by the observation that 
administration of proteolytic enzymes can enhance 
deposit removal, whether given acutely in large doses 
(Nakazawa et al. 1986a) or more chronically in. smaller 
doses (Nakazawa et al. 1986b) but such studies are 
highly artificial, and macrophages are not the only 
potential source of proteolytic enzymes. Jennette et al. 
(1987) concluded that the administration of amidine-type 
protease inhibitors could decrease glomerular injury in 
a chronic serum sickness model, but. despite., studying 
numerous inhibitors no change was seen in the amount. or 
site of immune complex localization. 
, ý, ý 
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It is' therefore open to question whether 
macrophages are involved in the removal of mesangial 
immune complexes after the initial phase 'of 
accumulation. The involvement of 'macrophages in the 
removal or modification of subepithelial deposits seems 
even less likely, as macrophages do not normally gain 
access to this space unless glomerular crescents are 
formed. The relevance of macrophages to deposit removal 
will be considered further in this thesis. 
Removal by complement 
The involvement of the constituents of the immune 
deposits in their own removal has been the subject of 
some study. The frequent observation of complement 
components co-localizing with other constituents of 
electron dense deposits has led to the belief that 
complement becomes intimately enmeshed in the deposits 
and contributes to their bulk. This has been reinforced 
by the observation that the deposits in acute serum 
sickness may contain copious amounts of C3 when the 
known antigen is barely detectable (Fish et al. 1966). 
Although complement presumably does contribute to the 
mass of the deposits, activated C3 is unlikely to be an 
inert component. There is abundant evidence that 
complement can dissolve immune complexes in the 
circulation (reviewed by Schifferli et al. 1986) : and 
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there is a single report in the literature indicating a 
similar function with immune complexes in glomeruli. 
Bartolotti & Peters (1978) depleted complement, by giving 
cobra venom factor to rabbits with acute BSA serum 
sickness, four days after immune elimination of the 
antigen from the circulation. The rate of removal of. BSA 
from the glomeruli of these rabbits was significantly 
reduced, though proteinuria was not affected. Bartolotti 
and Peters (1979) subsequently reporte'4 that sections. of 
kidney from rabbits with acute serum sickness at the 
time of glomerular deposition could activate complement 
by alternative or classical pathways, but that a few. 
days after deposition this capacity was lost, again 
indicating a change of the properties of the immune 
complexes with time. 
Removal by antigen and antibody 
Despite the observation that the deposits appear to 
grow by 'molecular accretion', it has been known for 
some time that intravenous administration of large 
amounts of antigen can lead to the removal of deposits 
(Valdes et al. 1969). It has been claimed that a large 
excess of antibody can have the same effect (Pusey et 
al. 1988); such an excess might inhibit deposition but 
there is no published evidence that removal is enhanced. 
By analogy with the observations on immune complex'size 
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described in the previous chapter, the effect of excess 
antigen was presumed to be due to the interference with 
the immune lattice and the generation of small soluble 
complexes, a theory supported by the observation that 
this can occur after the production of deposits by 
administration of pre-formed immune complexes, where the 
host immune system is unlikely to be involved (Mannik & 
Striker 1980). Penner et al. (1979) studied this 
phenomenon in vitro, by incubating frozen sections of 
kidney from rabbits with chronic BSA serum sickness with 
excess BSA. In early lesions this caused the removal of 
the deposits, as assessed by immunofluorescence, but 
after glomerulonephritis had been present for several 
weeks the deposits were only removed by incubation with 
excess BSA followed by heat-aggregated IgG. This 
supports the importance of the later accumulation of 
anti-idiotype or rheumatoid antibodies mentioned above. 
Haakenstad et al. (1983) found a similar time dependency 
of dissolution by antigen in vivo, again using chronic 
serum sickness; dissolution became only partial after 
chronic serum sickness had persisted for six weeks. 
Dissolution by antigen appears to be a phenomenon 
largely confined to mesangial deposits but it has 
recently been shown that this may be due to the limited 
access of excess antigen to subepithelial deposits; an 
excess of cationic antigen, which crosses the basement 
membrane more readily, can remove subepithelial deposits 
(Agodoa & Mannik 1987). These interesting observations 
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may have therapeutic implications in cases where the 
antigen can be identified but their relevance to the 
unmodified pathophysiology of glomerular disease is less 
clear. 
It is evident that recent advances in our 
understanding of the mechanisms by which glomerular 
immune complex deposits form have not been matched by 
advances in understanding of how they may be removed; 
this is particularly true in the case of subepithelial 
deposits. Even where advances have been made, the 
possibility that deposits in different sites, of 
different age and in different models may be very 
different has rarely been addressed. These observations 
prompted the work described in this thesis. 
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EXPERIMENTAL WORK 
There are two main prerequisites for a study of the 
factors involved in the removal of antigens and deposits 
from the glomerulus; an appropriate animal model, and a 
method for measuring the quantities of antibody and 
deposits in glomeruli. 
The ideal model should have the following 
characteristics: 
1) The pathogenesis, morphological changes and 
functional abnormalities should closely resemble a 
form of human disease. 
2) Disease of comparable severity should be induced in 
all the animals treated. 
3) The induction of disease should be reasonably easy 
and rapid. 
4) The morphological and functional changes induced 
should be well characterized. 
5) There must be a method of stopping deposit 
accumulation at a known time, so that removal can 
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be studied without interference from continuing 
deposition. 
6) After antigen/antibody deposition has stopped, the 
rate of removal of antigen and deposits from the 
glomerulus should be measurable and should be of a 
magnitude such that an increase or decrease in the 
rate which is induced by experimental manipulation 
can be of a size which is detectable. 
The requirement of sudden cessation of deposition 
makes many of the available models unsuitable. In 
autoimmune models such as Heymann nephritis, the only 
way to end deposition suddenly would be to transplant 
the kidney into a syngeneic, non-immune rat. Even this 
may not be appropriate or possible in virus-induced or 
inherited forms of animal glomerulonephritis. 
Transplantation to a 'clean' host has several 
disadvantages; the kidney suffers a variable degree of 
ischaemia and trauma and the time-consuming nature of 
the procedure would severely limit the number of'animals 
which could be studied, thereby limiting this 
investigation to relatively few variables. The serum 
sickness models provide an alternative approach; the 
injections of antigen or immune complexes can be 
stopped, but there then remains a problem of continued 
antigen deposition for an unknown time, and potential 
relocation of intact antigen from other organs to the 
kidney. Transplantation would again avoid these problems 
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but at the expense of the difficulties outlined above. 
An alternative approach is. to wait after the last 
antigen dose until all measurable parameters indicate 
that antigen deposition in the kidney has ceased before 
attempting to influence the rate of antigen removal. 
This approach has been used before (Bartolotti and 
Peters 1978) and was chosen for the work, to follow. 
The model should resemble a human disease in 
morphology and pathogenesis. This requirement is 
unavoidably difficult to fulfil, because so little is 
known about the pathogenesis of human 
glomerulonephritis. One can only choose a model which 
appears to resemble human disease in morphology and in 
the functional and biochemical abnormalities induced. 
These factors favour a chronic model which induces 
glomerular electron dense deposits and either nephritic 
or nephrotic syndrome. 
I therefore decided to study chronic serum sickness 
glomerulonephritis. The main problem with this model is 
its unpredictability, described in Chapter 2, unless 
antigen doses are matched to antibody response, which 
would again be laborious and limit the number of animals 
available for study. 
The unpredictability of chronic serum sickness 
appeared to be potentially subject to improvement by two 
other routes. The first was the choice of experimental 
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animal. Rabbits have been most widely used: these are 
outbred animals and individuals are known to produce 
unpredictable antibody responses to identical stimuli. 
Rats from a single local colony might produce a more 
homogeneous antibody response. Chronic serum sickness 
has been described in rats (Fennel & Pardo, 1967, Arisz 
et al. 1979, Yamamoto et al. 1978,1983, Miyazaki et al. 
1985 a& b) but the rat is more resistant to 
glomerulonephritis, and unusual immunization and dosage 
regimens have been employed, often in spontaneously 
hypertensive rats. The second potential area of 
improvement was in the choice of antigen. The recently 
proposed theory of in situ binding of cationic antigens 
to the glomerular wall, with subsequent binding of 
antibody, might if correct reduce the critical 
dependency on antibody response by eliminating the 
importance of immune complex size. The reported 
increased nephritogenicity of cationic antigens might 
also be expected to facilitate the development of a 
model in the rat. I therefore decided to study chronic 
serum sickness in theýrat, initially using either native 
or chemically cationized bovine serum albumin as 
antigen. 
The second prerequisite of this study was a method 
of measurement for antigen and deposits in glomeruli. 
The identification of a known antigen in glomeruli has 
usually been achieved by immunofluorescence or a related 
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technique. Such methodslend themselves at best only to 
semi-quantitative evaluation. Administration of radio- 
labeled antigen would permit, more precise quantitation. 
Detection could then be achieved by a variety of means: 
1) Autoradiography. Counting of grains over glomeruli 
might permit accurate quantitation but as only a 
tiny fraction of antigen would localize in 
glomeruli, low isotope levels might make this 
impractical. 
2) Gamma counting of whole- renal cortex. This would 
not discriminate between isotope in glomeruli and 
that elsewhere in the kidney. 
3) Gamma counting of isolated glomeruli. This would 
require measurement of numbers of glomeruli. 
An isotope was therefore required with the following 
characteristics: 
1) An available method of binding or incorporation of 
the isotope into the protein antigen. 
2) An emission detectable by autoradiography. 
3) An emission detectable by gamma counting. (Liquid 
scintillation would be inappropriate with tissue 
fragments or homogenates). 
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4) A half life at least as long as the duration of the 
experiments. 
The isotope best fulfilling these criteria is 
iodine-125, which has a half life of 60 days, is 
detectable by autoradiography and gamma counting, and 
can readily be attached to protein antigens. 
Electron dense deposits can only be observed by 
electron microscopy. There. is no reported method of 
quantitative extraction or staining; the only available 
technique is morphometry at electron microscopy level. 
Though laborious, this has the advantage of permitting 
separate analysis of deposits in different locations in 
the glomerulus. 
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Native bovine serum albumin was obtained from Sigma 
(A7030: essentially fatty acid and globulin free). 
Cationization of BSA Native BSA is anionic at 
physiological pH (pI 4.6). To make this substance 
cationic without substantially altering its 
antigenicity, the method of Hoare and Koshland (1967) 
was used, as suggested by Border et al. (1982). A water 
soluble carbodiimide (1-ethyl-3(3-dimethylaminopropyl) 
carbodiimide) is used to create a covalent bond between 
carboxyl groups of the protein and ethylenediamine, a 
small, strongly cationic molecule. Hoare and Koshland 
suggested the reaction to be as follows: 
Initial reaction of the carbodiimide group with a 
carboxyl group of the protein produces an 0-acylisourea: 
R' R' (1) 
0N0 NH 
II II II 
RC-OH +C+ H+ 
-4 RC-O-C 
II II 
N NH+ R 
-BSA 
R'-ethyl 
R" R" R"=dimethylaminopropyl 
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This may then re-arrange to produce an N-acylurea: 
R' RC=O (2) 
0 NH NR' 
II 
RC-O-C 
-9 0=C + H* 
II 
NH+ NH 
R" R" 
or react with a nucleophile such as ethylenediamine: 
R' R' (3), 
1 
0 NH 0 NH 
II I II 
RC-O-C + H2N-C2H2-NH2 
-4 RC-NH-C2H2-NH2 + 0=C + H+ 
II 1 
NH+ NH 
R" R.. 
or water: 
R' 
O NH 
II 
RC-O-C 
11 
NH4 
R" 
0 
11 
+ H2O 
-4 RC-OH 
R' (4) 
1 
NH 
+ 0=C + H+ 
NH 
R" 
which regenerates the carboxylic acid. 
The reaction is stopped by adding an excess of an 
acetate buffer, which reacts with and eliminates any 
remaining carbodiimide. 
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This reaction was proposed by Hoare and Koshland as 
a quantitative method to substitute the nucleophile to 
all available carboxyl groups of the protein. Of the 
reactions (2) to (4), only (3) has this effect. Reaction 
(3) is favoured over reaction (4) at more acid pH, and 
was reported to be the main reaction at pH 4.75. In my 
hands, this reaction resulted in a product with a pI of 
over 11 (vide infra) which was, toxic, despite careful 
aseptic technique, passage through a 0.2 µm filter and 
confirmation by thin layer chromatography that none of 
the original reagents remained after the final dialysis. 
The reaction conditions were therefore modified to 
give a slightly less cationic product, and carried out 
at pH 5.5, to enhance reaction (4) at the expense of 
(3), as described in Appendix 1. 
Characterization of the antigen 
The pI of each batch of cationic BSA was measured 
by isoelectric focussing on thin cellulose acetate 
membranes (Ambler & Walker 1970) using ampholines with a 
pH gradient of 2 to 11 (Serva) 
. 
The batch of BSA was 
rejected if the main band had a pI outside the limits of 
8 to 10. (Appendix 2) 
To exclude the presence of aggregates, an iodine- 
125 labeled sample from each of the first two batches 
was layered on to a 12-38% sucrose gradient and spun for 
8 hours at 50,000 r. p. m. in a Sorvall OTD-65 
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ultracentrifuge in an AH650 head'. Seventeen fractions 
were collected and counted. Only one peak was 
identified; there was therefore no evidence of dimers or 
larger aggregates (Appendix 3). 
When an experiment was planned which would require 
the use of -radiolabelled antigen, Iodine-125 was 
obtained from Amersham (EMS30) at an activity of 74MBq 
per experiment. Cationic and/or native BSA was labeled 
by a Chloramine T method, as described in Appendix 4. 
Samples taken before and after dialysis indicated 
that the efficiency of iodination was never less than 
85%. Precipitation of the protein from the final product 
with trichloracetic acid left less than 2% of the 
activity in the supernatant. 
The radio-labeled protein was mixed with sufficient 
unlabeled antigen to complete the experiment, at a 
concentration of 100mg/ml. This was then separated into 
an appropriate number of aliquots (usually seven) and 
stored at 
-20 C until required. 
- 
66 
- 
Chapter 4 
Protocol 
Establishing the model 
Male Wistar rats, initial weight 100-125g, were 
used throughout the experimental work. In the 
experiments designed to establish and characterize the 
model, a single untreated rat was kept in. each cage, to 
confirm variation from the normal and to exclude 
possible effects of infection in the colony. 
To establish an immune response, three different 
adjuvant regimes were assessed, using 1mg of either 
native or cationic BSA as antigen in every case: 
1) Antigen with 1µg of Escherichia coli endotoxin 
(Sigma), intravenously, seven days before starting 
regular injections of antigen. 
2) Antigen in 0.25m1 saline with 0.25m1 of Freund's 
incomplete adjuvant (FIA) subcutaneously to the 
back of the neck, 22 days, and again 10 days before 
starting regular injections. 
3) Antigen in 0.25 ml saline with 0.25m1 of Freunds 
complete adjuvant (FCA), subcutaneously to the back 
of the neck, 22 days and again 10 days before 
starting regular injections. 
Each group contained six, rats immunized with each 
of the antigens (a total of 36 rats). Pairs of rats were 
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then given the appropriate-antigen by thrice weekly 
tail-vein injection for two months, in doses of 0.1mg, 
lmg or 10mg, in every case in 0. lml of saline. After 
eight weeks the rats were killed by exsanguination under 
anaesthetic (Hypnorm® and diazepam). Samples of renal 
tissue were taken into formalin for light microscopy 
(Appendix 5) and into 2.5% glutaraldehyde for electron 
microscopy (Appendix 6). Paraffin sections were stained 
conventionally with haematoxylin and eosin. Tissue for 
electron microscopy was post-fixed in osmium tetroxide 
and processed into Epon resin. Thin sections (0.5µm) 
were cut and stained with Toluidine Blue to identify a 
suitable area for study, then ultrathin sections were 
cut, stained with uranyl acetate and lead citrate, and 
examined in a JEOL 1200EX transmission electron 
microscope at 80KV. 
Serum samples were taken from each rat at the end 
of the experiment. Ouchterlony plates were used to 
identify the presence of an antibody response and to 
assess the degree of identity between antibodies raised 
against native or cationic BSA (Appendix 7). 
Results 
One rat which had been immunized with FCA died 
within minutes of receiving its first intravenous dose, 
which was 10mg of cationic BSA. This was presumably due 
to hypersensitivity in an animal with high circulating 
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antibody levels. There were no other unexpected 
complications. 
None of the rats showed any detectable alteration 
in glomerular morphology as assessed by light microscopy 
of paraffin sections. The results of the electron 
microscopy study are shown in Table 1. Rats immunized 
with endotoxin or with FCA developed no lesions 
detectable by electron microscopy. In animals immunized 
with FIA, administration of native BSA produced only 
mesangial electron dense deposits. These were present in 
every glomerulus of rats given lmg. (Fig. 1) A dose of 
10mg produced only occasional small deposits, and after 
0. lmg no deposits were found at all. In contrast, 
cationic BSA produced subepithelial and mesangial 
deposits. The lowest dose produced no deposits but they 
were readily found in both locations in rats given lmg 
and they were large and very numerous in rats given 10mg 
(Fig. 2). 
Table 1. The effect of variations in immunization 
schedule and antigen dose on glomerular morphology. 
Antigen: Native bovine serum albumin 
Antigen 
dose 
Endotoxin FIA FCA 
0.1mg No deposits No deposits No deposits 
1mg No deposits Numerous mesangial No deposits 
deposits 
10mg No deposits Few mesangial No deposits 
deposits 
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Antigen: Cationic bovine serum albumin 
Antigen Endotoxin FIA FCA 
dose 
0.1mg No deposits No deposits No deposits 
1mg No deposits Occasional subepithelial No deposits 
and mesangial deposits 
10mg No deposits Numerous subepithelial No deposits 
and mesangial deposits 
Foot process effacement 
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Figure 1. Mesangial deposits in a rat which had received 
1mg doses of native BSA. 
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The Ouchterlony diffusion plates did not detect any 
antibody in rats immunized with endotoxin or in rats 
given 10mg of either antigen 
- 
presumably because these 
large doses had caused consumption of most of the 
antibody produced. In rats given FCA or FIA and 
subsequent doses of lmg or 0. lmg of antigen, lines of 
precipitate were evident, with a single line of identity 
between samples from rats immunized with either antigen. 
Conclusions 
The results of this experiment were used to assess 
the best conditions to induce chronic serum sickness 
- 
71 
- 
Figure 2. Numerous subepithelial and mesangial deposits 
in a rat which had received 10mg doses of cationic BSA. 
Chapter 4 Establishing the model 
glomerulonephritis. In every subsequent experiment, the 
rats were therefore immunized twice with lmg of antigen 
in Freund's incomplete adjuvant, and thrice weekly 
injections were given of lmg of native BSA or 10mg of 
cationic BSA, in 0. lml of saline. 
Other conclusions can also be drawn from these 
results. The presence of subepithelial deposits only in 
rats given cationic BSA confirms the findings of Border 
et al. (1982) and supports the theory that cationic 
antigens can bind directly to glomerular anionic sites, 
with subsequent binding of antibody. The simultaneous 
presence of mesangial deposits suggests the possibility 
that deposition of whole circulating immune complexes 
may also be occurring in the cationic BSA model. 
The dependence of the native BSA model on antigen 
dose is well known and is described in Chapter 2. The 
number of rats studied here is small, but the apparent 
absence of an optimal nephritogenic dose for cationic 
BSA also supports the theory of 'in situ' binding of 
antigen, as it implies that the size of any circulating 
immune complexes is not critical. 
The absence of any deposits in rats which received 
only endotoxin as adjuvant is explained by the apparent 
absence of an antibody response in those animals. The 
absence of deposits in rats which received FCA is more 
complex. Antibody levels were not measured but if these 
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were higher after FCA, one would have expected the 
higher dose of native BSA to restore the balance; with 
cationic BSA the antibody level is probably less 
important. The alternative explanation is that FCA has 
caused increased activity of the mononuclear phagocytes, 
with more rapid antigen clearance. Such clearance could 
occur before the antigen reach the glomerulus, but there 
could also be more rapid removal from the glomerulus 
immediately after deposition. Other studies were planned 
to Investigate these points but it was first necessary 
to further characterize the experimental models. 
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Having established conditions under which rats 
would develop glomerular deposits after eight weeks of 
antigen injections, it was necessary to document the 
speed with which such deposits formed, and any changes 
in the composition of blood or urine which were induced 
during that period. A parallel experiment was performed 
to evaluate the intramuscular administration of antigen. 
This route would, if successful, reduce the 'bolus' 
effect whereby an intravenous injection causes a brief 
but considerable circulating antigen excess. It would 
also increase the speed with which experiments could be 
performed. 
Animals were immunized as described above, using 
either native BSA (15 rats) or cationic BSA (15 rats). 
Thrice weekly intravenous injections were then given of 
the appropriate antigen at a dose of lmg (native) or 
10mg (cationic). Five rats from each group were killed 
after two weeks, four weeks and eight weeks. The last 
antigen dose was in every case given 24 hours before 
death and was labeled with iodine-125. At sacrifice, 
samples were taken of blood, renal cortex, liver, spleen 
and lung. The tissue samples were weighed and submitted 
to a gamma counter. Renal tissue was processed for 
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electron microscopy; all tissues were processed for 
light microscopy and autoradiography (Appendix 8). Full 
blood counts were performed using a Coulter counter with 
the assistance of the Department of Haematology. Serum 
urea, albumin, cholesterol and triglyceride were 
measured on a Hitachi 712 Autoanalyzer with the 
assistance of the Department of Clinical Chemistry. 
Samples from six normal rats were included to establish 
a normal range. All the animals were weighed before and 
after the course of injections. Three rats from each of 
the two groups surviving for eight weeks were kept in 
metabolic cages and 24 hour urine collections were made 
to assess proteinuria at 0,2,4 and 8 weeks. Protein 
concentrations were measured by the sulphosalicylic acid 
technique (Appendix 9). 
To assess the effect of intramuscular 
administration of antigen, three groups of six rats each 
were immunized with FIA and native BSA, cationic BSA or 
saline. Each group of six was then divided into two 
groups of three, and given the appropriate antigen by 
tail-vein or intramuscular administration (native lmg, 
cationic 10mg) thrice weekly for four weeks. 
Intramuscular injections were given to the musculature 
of the hind leg on alternate sides. Renal tissue was 
then taken for light and electron microscopy. 
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To confirm that the observed difference-in the 
effects of the two antigens was due to the regular 
injections rather than the initial immunization, two 
groups of three rats each were immunized with FIA and 
antigen as before, but were then given the other antigen 
for three weeks before death and sampling of renal 
tissues. 
To assess the influence of antigen dose on the size 
of any circulating immune complexes, pairs of rats were 
immunized as above against native or cationic BSA, then 
given 0.1mg, 1mg or 10mg of the appropriate antigen by 
intramuscular injection thrice weekly for two weeks. The 
last dose was labeled with iodine-125 and the rats were 
killed by exsanguination under anaesthetic three hours 
later. The blood was allowed to clot at 38 C; serum was 
collected and stored in liquid nitrogen. Samples were 
layered on to sucrose gradients (12%-28%) and spun for 6 
hours at 55,000 r. p. m. in a Sorvall OTD-65 
ultracentrifuge in an AH650 head (Appendix 3). Samples 
of labeled native BSA and human IgG were also spun as 
molecular weight markers. The tubes were cut into 17 
fractions and submitted to the gamma counter. 
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Morphology. No changes were detected by light 
microscopy of the glomeruli of any of the rats at any 
time, irrespective of the antigen dose. Electron 
microscopy showed that all the rats receiving 10mg of 
cationic BSA had subepithelial and mesangial electron 
dense deposits by two weeks, with foot process 
effacement. An impression was gained that these changes 
were more severe at four and eight weeks but as 
quantitation was not attempted this could not be 
confirmed. One of the rats receiving 1mg of native BSA 
had occasional mesangial deposits at two weeks; the 
others remained normal. At four weeks three of the five 
rats killed in this group had mesangial deposits. By 
eight weeks mesangial deposits could be found in all 
five rats, though they were infrequent in one. In all 
the rats given native BSA the capillary loops remained 
morphologically normal, with no deposits and no foot 
process effacement. 
Tissue antigen load. The amount of radio-labeled 
antigen remaining in renal cortex 24 hours after the 
last dose was higher than in any other tissue and was 
higher for cationic BSA than native BSA. The amount of 
antigen deposited in the kidney appeared to be fairly 
constant over the course of the experiment (Table 2 ). 
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Table 2 Percentage of one dose of radio-labeled BSA in 
each gram of renal cortex 24 hours after administration. 
Dura 
2 weeks 
tion of 
4 weeks 
disease 
8 weeks 
Native BSA (%/g) 0.108 0.111 0.107 
(±95% limits) (±0.018) (±0.013) (±0.027) 
Cationic BSA (%/g) 0.226 0.155 0.206 
(±95% limits) (±0.044) (±0.023) (±0.017) 
Autoradiography An exposure of two months was 
required before adequate autoradiographs were produced. 
Even then, the number of grains over each glomerulus 
varied considerably and it was obvious that this method 
was not suitable for the quantitation of glomerular 
antigen load. Nevertheless, some information was gained. 
The only structures with detectable activity by this 
method were the glomeruli, which indicated that 
measurement of the isotope content of whole renal cortex 
would give at least an approximation of the isotope 
levels in glomeruli. The pattern of silver grains 
reflected the diffuse mesangial and capillary loop 
localization of the deposits after cationic BSA, and the 
more localized mesangial pattern of the deposits after 
native BSA. 
Hacnatology Rats receiving cationic BSA for eight weeks 
developed low haemoglobin and raised reticulocyte 
counts, indicating a hemolytic anaemia (Table 3). 
Numbers of leukocytes and platelets showed no 
significant change. 
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Table 3. Haemoglobin and reticulocyte count of control 
and serum sickness rats at eight weeks. 
Control Native BSA Cationic BSA 
Haemoglobin (g/dl) 14.3 13.5t_ 10.7* 
(± 95% limits) (±0.3) (±0.46) (±1.02) 
Reticulocytes (%) 1.6 2.1 6.3* 
(± 95% limits) (±0.54) (±0.61) (±1.8) 
t: p<0.05 
*: p<0.01 by Student's t test 
Biochemistry Changes in serum urea, albumin, 
cholesterol and triglyceride are illustrated in Figures 
3 to 6. None of the groups showed any significant 
difference in urea, but by two weeks the rats receiving 
cationic BSA had low serum albumin and high cholesterol 
and triglyceride. These abnormalities persisted for the 
rest of the experiment. 
Figure 3 
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Figure 4 
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Figure 6 
Tricyoeride 
15 
10 
0 E 
5 -"f- 
p<0.01 
45- 
0 
0246 
Weeks 
Proteinuria. The protein output of the groups of rats 
is shown in Fig. 7. By two weeks, cationic BSA serum 
sickness had caused proteinuria in all the rats 
examined. This persisted and became heavier throughout 
the experiment. None of the rats receiving native BSA 
developed proteinuria. 
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Figure 7 
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Weight. The rats used in this study had not attained 
their final adult weight, but rats with cationic BSA 
serum sickness virtually stopped gaining weight, despite 
having ascites (Table 4). Native BSA serum sickness also 
inhibited normal weight gain, despite the absence of any 
detectable renal functional impairment. 
Table 4. Weight gain of rats per week 
Control Native BSA Cationic BSA 
Average weight 
gain per week 24g llg lg 
(±95% limits) (±3.2g) (±2.0g) (±3.1g) 
Intramuscular administration. The rats which had 
received cationic BSA by ; rtramuscular injection for 
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four weeks had glomeruli which showed abnormalities at 
electron microscopy which were indistinguishable from 
those seen after intravenous injection. The rats given 
native BSA by intramuscular injection had no detectable 
deposits, and only one of the three rats given native 
BSA by intravenous injection had mesangial deposits. 
Tissue damage at the injection sites in the legs 
was not detected on macroscopic examination. 
Effect of initial immunization. The rats which were 
initially immunized with one antigen then given regular 
doses of the other developed glomerular lesions 
consistent with the antigen given by regular injection, 
not the antigen given initially in FIA. 
Effect of dose on circulating immune complexes 
The results of the ultracentrifugation study for animals 
receiving native BSA are shown in Fig. 8. They indicate 
that three hours after the optimum dose of 1mg, most of 
the isotope is present in the serum in a form at or 
above the weight of one molecule of IgG: that is, as 
small immune complexes. A dose of 10mg produced mainly 
free BSA at this point. 
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Figure 8 
Evaluating the model 
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An attempt to perform a similar analysis using 
cationic BSA failed; contrary to previous reports 
(Border et al. 1982) only a trace amount of isotope was 
present in the serum and this had the mobility of free 
iodine. The finding of an autoimmune haemolytic anaemia 
described above suggested that at least some of the 
cationic BSA might be binding to erythrocytes. To test 
this, about 1µg of radio-labeled cationic or native BSA 
was injected into two non-immune rats. After 30 minutes 
blood samples were taken and allowed to clot. Serum and 
clot were separated and counted. The results (Table 5) 
indicate that cationic BSA does tend to remain in the 
clot, presumably due to charge interactions with the 
erythrocytes. 
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Table 5. Separation of native and cationic BSA with 
serum or blood clot. 
Native BSA Cationic BSA 
Percentage of 
counts in blood clot 13 92 
Percentage of 
counts in serum 87 8 
These results indicated that biochemical and renal 
abnormalities which are characteristic of nephrotic 
syndrome can be reliably and relatively rapidly induced 
by pre-immunization with antigen in FIA followed by 
seven doses of cationic BSA, spread over two weeks. This 
result can be achieved by either intravenous or 
intramuscular administration of antigen. Intramuscular 
administration reduces the 'bolus' effect described 
above, and it is more convenient and less distressing to 
the animals. This mode of induction of 
glomerulonephritis was therefore adopted for all the 
subsequent experiments. The more classical native BSA 
model was studied in parallel but this antigen was much 
less reliable in inducing deposits, and did not induce 
any detectable abnormality in renal function. Its use 
was therefore dropped. 
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The studies of antigen location indicated that 
-I though the kidney was a- preferred site of a. Ligen 
accumulation, only a tiny proportion of the injected 
dose was deposited there; and although most of this was 
deposited in glomeruli, autoradiography was not a 
suitable tool to assess any alterations in glomerulus 
antigen load and other methods would be required. 
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To assess further the development of this form of 
chronic serum sickness glomerulonephritis, a sequential 
study was performed to correlate the morphological 
changes in the glomerulus with the level of proteinuria, 
during the development of and recovery from 
glomerulonephritis. To obtain optimal ultrastructural 
detail, the kidneys were fixed by a modification of the 
surface fixation technique of Griffith et al. (1967). 
Chronic serum sickness glomerulonephritis was 
induced in 24 male Wistar rats using cationized bovine 
serum albumin and an immunization schedule with Freund's 
incomplete adjuvant as described in Chapter 4. 
Intramuscular injections of 10mg of cationized BSA were 
given thrice weekly for two weeks (seven injections). 
During the induction of glomerulonephritis and thrice 
weekly during recovery, one of the rats was placed in a 
metabolic cage and a 24 hour collection of urine was 
made, for estimation of proteinuria by the 
sulphosalicylic acid method (Appendix 9). After that 
collection the rat was anesthetized (Hypnörm® and 
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Diazepam), the abdomen was opened and the left kidney 
exposed. The renal capsule was peeled back. A lcm long 
section of plastic tubing, lcm in external diameter, was 
attached to the surface of the kidney using 'Super Glue' 
(Cyanoacrylate ester; 'Loctite Super-Glue Extra'®). This 
created a watertight well on the surface of the kidney, 
which was filled with Karnovsky's fixative (Fig. 9). 
Figure 9. Method of surface fixation of the kidney in 
the live, anaesthetized animal. 
ý: Fixetive 
Renal cortex 
Plastic 
ring 
Super- 
alue 
This modification of previously described surface 
fixation methods (Griffith et al. 1967) eliminated the 
exposure of other abdominal organs to the fixative, 
allowing a fixation period of two hours in the live 
anesthetized animal. By this method good fixation of 
glomeruli was achieved in the Wistar rat, without having 
to resort to the more superficial glomeruli of the 
Munich-Wistar strain. 
After two hours of surface fixation the kidney was 
excised and the animal killed by exsanguination. The 
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surface fixed area of kidney was sliced off and placed 
in Karnovsky's fixative for a further period of up to 24 
hours. Small samples (lmm) were taken and processed 
routinely into Epon resin for transmission electron 
microscopy (Appendix 6) and examined in a JEOL TEM 800X 
at 80KV. A slice approximately 0.5mm thick was then 
removed by hand from the surface of the rest of the 
specimen, to expose surface-fixed glomeruli. The tissue 
was processed for scanning electron m4.: roscopy (Appendix 
10) and examined in a JEOL JSM 35 at 20KV. 
Results 
Proteinuria. The normal low level of proteinuria in 
this species (less than 5mg/24 hours) was not exceeded 
until the 9th day of induction (5 injections), when a 
value of 9.3mg/24h was recorded. The subsequent values 
are shown in Fig. 10. There is great variation, probably 
because each bar represents a different experimental 
animal, but after day 10 proteinuria was never found to 
be below 20mg/24h until the animal killed on day 33, 
after 18 days of recovery. 
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Figure 10 
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Morphology. The earliest abnormal morphological 
findings were seen in the rat killed on day 3,1 hour 
after the second antigen injection. Small electron dense 
deposits were occasionally seen in subepithelial and 
mesangial locations (Figure 11), but foot process 
effacement was not evident on scanning or transmission 
electron microscopy. Deposits were not seen in the rat 
killed on day 4, but were present in all subsequent 
animals except on day 33. Scanning electron microscopy 
revealed short microvillous processes on the external 
surfaces of the epithelial cells on day 3; these became 
more numerous as the disease progressed and never 
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completely resolved in the course of the experiment 
(Fig. 12). Foot process effacement was seen from day 7 
onwards, two days before the onset of proteinuria 
(Fig. 13). The development of proteinuria correlated 
best with the appearance of large- swellings or 
'balloons' beneath the epithelium (Fig. 14). This 
phenomenon could only be peen in surface fixed 
glomeruli; in deeper glomeruli the 'balloons' had 
presumably collapsed. Balloons have been described 
before in Puromycin nephrosis in the rat (Messina et al. 
1987), where they also correlate well with the onset of 
proteinuria. Near-normal foot processes could be seen in 
the base of many of the balloons. In contrast to the 
features described in Puromycin nephrosis, areas of 
basement membrane without an epithelial covering were 
not detected. 
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Figure 11. Day 3. Small subepithelial deposits are 
present. Transmission electron micrograph, x 15,000. 
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Figure 12. Microvillous processes on the external 
surface of the epithelial cells. Scanning electron 
micrograph, x 4,300. (Foot process effacement is 
advanced in this rat). 
Chapter 6 Morphology 
- 
93 
- 
Figure 13. Day 7. The first evidence of foot process 
effacement. Scanning electron micrograph, x 4,600. 
Figure 14. Epithelial 'balloon'. Transmission electron 
micrograph, x 8,000. 
Chapter 6 Morphology 
These results indicated that there is a rather poor 
temporal correlation between the development of electron 
dense deposits and the onset of proteinuria. The 
immunization regimen used produced deposits after only 
two injections. Proteinuria was not seen for another six 
days, but continued to get worse after the injections 
ceased. This finding, and the considerable variation of 
proteinuria between animals, suggested that urinary 
protein levels would not provide a useful index of 
glomerular antigen deposition in the work to follow. 
A mechanism has been proposed to explain the 
formation of the balloons in Puromycin nephrosis. 
Messina et al. (1987) suggested that foot process 
effacement first leads to the formation of a continuous 
sheet of epithelial cell cytoplasm over the basement 
membrane. A focal detachment of this sheet permits an 
increased flux of fluid across the basement membrane, 
and a blow-out of the epithelial cytoplasm results. My 
results do not support a similar mechanism in chronic 
serum sickness, because: i) foci of bare basement 
membrane could not be found, and ii) the presence of 
interdigitating foot processes at the base of the 
balloons means that a single cytoplasmic sheet could not 
have been present, because alternate foot processes 
arise from different epithelial cells (Arakawa 1971). A 
study of balloons of different sizes suggests that in 
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chronic serum sickness glomerulonephritis the balloons 
arise as a result of containment of ultrafiltrate 
between the epithelial cells (Fig. 15 and legend). 
Figure 15. Epithelial balloons of various sizes. The 
suggestion is made that if the derangement of podocyte 
structure which is associated with proteinuria causes 
obstruction of the escape of filtrate from the space 
marked with an arrow, then a progressive dilatation of 
the space will result, possibly producing the balloons 
seen at the top of the picture. Transmission electron 
micrograph, x 7.500. 
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Chapter 7 
The results of the experiments described above 
indicated that an immune complex glomerulonephritis and 
nephrotic syndrome could reliably be induced in immune 
rats after only seven intramuscular injections of 
cationic BSA. A basic protocol was the: afore devised for 
the induction of glomerulonephritis and the-assessment 
of the load of antigen and deposits in glomeruli. The 
following procedures were followed in all subsequent 
investigations unless varied as stated in the text. 
Male Wistar rats, initial weight 100-125g, were 
used throughout. 
Initial immunization was achieved by subcutaneous 
injection of an emulsion of 0.25m1 of Freund's 
incomplete adjuvant and 0.25m1 of saline containing lmg 
of cationic BSA, 22 days and again 10 days before 
starting regular injections. A batch of cationic BSA was 
labeled with Iodine-125 as described above (Appendix 4), 
divided into seven aliquots at a concentration of 
100mg/ml, and stored at 
-20'C. Aliquots were thawed as 
required and administered to the rats as O. lml 
injections to the musculature of the hind leg on 
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alternate sides. Each group-of rats'received seven such 
injections over a two-week period. 
Procedure at sacrifice 
After the induction of glomerulonephritis and a 
period of recovery appropriate to the experiment being 
performed, the rats were anesthetized with Hypnorm® 
(0.2m1 i. m. ) and diazepam (0.2m1 i. p. ); the abdomen was 
opened and a small piece of renal cortex was taken, cut 
into lmm cubes and fixed in 2% glutaraldehyde for 
processing for transmission electron microscopy. If 
necessary, a blood sample was taken from the inferior 
vena cava. The aorta was clamped just below the 
diaphragm and cannulated just above its bifurcation. The 
inferior vena cava was opened and the abdominal organs 
were flushed with a minimum of 20m1 of saline via the 
aortic cannula. The kidneys were rapidly removed, and 
samples (50 
- 
100mg) of renal cortex, liver spleen and 
lung were taken, weighed and fixed in individual tubes 
of 10% formalin. These samples were subsequently 
submitted to the gamma counter for assessment of isotope 
content, then the tissues were recovered and processed 
to paraffin wax for sectioning. If required, samples of 
tissue were frozen in freezing isopentane and stored at 
-70°C. The rest of the kidneys was placed in saline at 
4°C for subsequent isolation of glomeruli. 
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A technique was developed by modification of the 
method described by Raij et al. (1979). The renal cortex 
was roughly cut from the medulla, and the latter 
discarded. The cortex was disrupted by pushing through a 
coarse nylon mesh, with copious phosphate buffered 
saline, pH7.4. Sieves had previously been prepared by 
sawing off the ends of 60m1 plastic syringes and 
covering the opening with stainless steel wire mesh 
(Greenings Ltd), 100 or 200 mesh, attached by a resin 
adhesive. The fragmented cortical tissue was poured into 
a 100 mesh sieve, which permits glomeruli to pass 
through, and was washed through with saline and gentle 
action of the plunger. The suspension which penetrated 
this sieve was poured into a 200 mesh sieve (which traps 
glomeruli) and washed several times with saline. 
Glomeruli were freed from the mesh by sucking saline 
into the syringe, removing the plunger and pouring the 
contents into a conical test-tube. The glomeruli settled 
to the bottom and the overlying saline was discarded to 
a volume'of approximately 0.7ml. This suspension was 
then agitated and a 10µl sample was placed on a glass 
slide with a cover-slip, for counting of numbers of 
glomeruli by conventional transmitted light microscopy, 
unstained. 500µ1 was then rapidly pipetted to a tube for 
measurement of isotope content. in a gamma counter.. 
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Initial evaluation of this technique by performing 
multiple replicate counts of glomeruli indicated an 
unacceptably high variation. This appeared to be due to 
adherence of glomeruli to glassware and pipette tips. 
Several substances were added in an attempt to reduce 
adherence. The addition of a few drops of a strong 
solution of (native) BSA before pipetting was found to 
be effective, 
-and variation was thus reduced to less 
than 5%. 
- 
The method typically produced a yield of 5,000 
to 10,000 glomeruli; the preparations were invariably in 
excess of 90% glomeruli, and usually in excess of 95%. 
The remainder appeared to be mainly small blood vessels. 
Samples of renal cortex fixed in glutaraldehyde 
were processed for transmission electron microscopy by 
routine methods (Appendix 6). Each rat was identified by 
a code number in the electron microscopy unit to 
eliminate subsequent observer bias. Photographs were 
taken at a magnification of x5,000, locating the 
aperture over a glomerulus at the intersection of the 
grid bars to provide a random selection of areas. No 
r 
glomerulus was photographed more than once. 
Electron dense deposits were outlined by pen on the 
resultant photographs, making a distinction between 
subepithelial and mesangial deposits. A transparent grid 
with points 0.2cm apart was laid over each photograph, 
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and points overlying the deposits were counted. This 
process was continued until the relative standard error 
of the measurement was 5% or, less (Aherne-& Dunnill 
1982); this required between 4 and 8 photographs from 
each rat. Volume fractions of mesangial and 
subepithelial deposits were calculated. In the 
experiments described after Chapter 8a SeeScan image 
analyser became available so the method was modified to 
take advantage of this. Clear acetate sheets were'laid 
over the. photographs and the outlines of the deposits 
were drawn on to the sheets, using a separate sheet for 
mesangial and subepithelial deposits. The image analyser 
was calibrated using an acetate sheet with a black 
square of known dimensions, then the acetate sheets were 
submitted and volume fractions calculated. All the 
measurements for one experiment were made in one 
session; reproducibility within one session was greater 
than 98%, but variations in illumination made comparison 
of measurements between sessions much less precise. 
To allow for any variation in glomerular size which 
might develop between experimental groups, paraffin 
sections stained with Hmmatoxylin and Eosin were 
examined with a light microscope using an eyepiece 
graticule, and the diameter of ten glomeruli was 
measured for every rat. If a significant difference was 
detected the fractional alteration in glomerular volume 
was calculated and the volume fraction results for the 
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relevant experimental group were corrected to the volume 
of its control group. This manoeuvre only proved to be 
necessary after the administration of polyvinyl alcohol 
(Chapter 12). 
Calculations were performed using an Amstrad 
PCW8256 microcomputer, using programs written for the 
purpose in BASIC or using the AMSTAT statistics package. 
The differences between means were assessed using 
Student's 't' test where the data was suitable, and Mann 
Whitney's 'U' test where it was non-parametric. 
Error bars on the histograms indicate 95% 
confidence limits. 
F 
- 
101 
- 
Chapter 7 Quantitation 
The intention of these experiments was to attempt 
to modify the rate at which antigen and deposits are 
removed from the glomerulus. However, if some form of 
intervention is applied immediately after the last 
antigen dose, its effects could be attributed just as 
readily to an influence on the deposition of antigen in 
the glomerulus as to an influence on its removal. 
Renal transplantation has been mentioned as a 
potential way of avoiding this problem. If an antigen- 
laden kidney is transplanted into a syngeneic antigen- 
free host, then the potential for late deposition of 
antigen is eliminated. To assess the feasibility of this 
approach, I learned the technique of orthotopic renal 
transplantation in the rat, with the assistance of 
members of the Nuffield Department of Surgery in Oxford. 
Preliminary experiments indicated that the inbred rat 
strain F344 is susceptible to the cationic BSA form of 
chronic serum sickness glomerulonephritis. 
Unfortunately, although transplantation of the normal 
kidney was achieved, re-perfusion of nephrotic kidneys 
was never established, despite intact anastomoses and 
attempts to supplement the standard method of 
anticoagulation by systemic heparin by perfusion of the 
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kidney with ice-cold heparinized 'kidney perfusion 
fluid' (formulated for human renal transplantation). As 
a result, and bearing in mind the other disadvantages of 
transplantation (ischaemia and the limited number of 
animals which could be studied), this technique was 
abandoned and experiments were carried out to assess the 
kinetics of antigen levels in the glomerulus after the 
last antigen dose, and to estimate how long after the 
last antigen dose relocation of antigen might still be 
occurring. 
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An experiment was performed to evaluate the rate of 
removal of antigen from the glomeruli after the 
cessation of injections, ' in the absence of any form of 
intervention. 
Chronic serum sickness glomerulonephritis was 
induced in 18 rats, using cationic BSA over 2 weeks as 
described above. The last injection only was "radio- 
labeled. Groups of 3 rats were killed 3 hours, 24 hours, 
2 days, 4 days, 7 days and 14 days after the last 
antigen injection. The three rats killed after 14 days 
were housed in metabolic cages throughout, to permit 
daily *24 hour urine collections for assessment of 
proteinuria. To determine the proportion of the isotope 
in the urine which was free iodine-125 (presumably 
released after degradation of antigen), 500µl of each 
sample was mixed with an equal volume of 10% 
trichloracetic acid, to precipitate protein. The 
supernatant was removed, the precipitate was washed, and 
supernatant and precipitate were submitted to the gamma 
counter. The volume fraction of the deposits and the 
amount of isotope in isolated glomeruli, renal cortex, 
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liver, spleen and lung were measured by the methods 
described in Chapter 17. In addition, whole blood , sämples 
were taken for assessment of isotope content. 
To confirm that the observed changes were indeed 
due to interactions between the antigen and the immune 
system, and were not. due to the properties of the 
cationic BSA itself, a further 18 rats were given six 
injections of 10mg of cationic"BSA followed by one of 
radiolabelled BSA, over two weeks, but without initial 
immunization. Samples of tissue were taken at intervals 
as in the above group, although urine was not collected 
and blood samples were used to confirm (by Ouchterlony 
immunodiffusion) that these- rats had not-made a 
significant antibody response. 
The amount of isotope in isolated glomeruli and 
whole tissues are shown in Figures 16 and 17. Each point 
represents the mean of values from the three rats killed 
at that time. 
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Figure 16 
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In non-immune- animals, the 'antigen "«-is x° rapidly 
eliminated, with little evidence of binding in glomeruli 
(Fig'. 16) or in other tissues. In chronic serum sickness 
it appears that antigen accumulation, in glomeruli and in 
lung is continuing between 3 and 24 hours after the last 
antigen dose, but after this time all the tissues 
examined showed a rapid fall in isotope levels 
(Fig. 17). This fall was least marked in glomeruli and 
renal cortex. Morphometric assessment of deposit volume 
fraction confirmed that subepithelial and mesangial 
deposits were being removed, though the changes were 
more rapid in the mesangial deposits (Fig. 18). 
. 
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Figure 18 
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Iodine-125 proved to be almost undetectable in the 
blood after two days. The level of proteinuria was found 
to continue to increase after the antigen injection 
ceased (Fig. 19), confirming the impression given by the 
results of Chapter 6. 
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Figure 19 
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The rate and "pattern of isotope excretion was of 
particular interest (Fig. 20). Most of the isotope was 
excreted very rapidly, and most was excreted as free 
isotope. Protein-bound isotope was undetectable in the 
urine after A days of recovery, despite continuing, heavy 
proteinuria. 
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Figure 20 
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The finding that isotope levels in immune rats 
decreased in all tissues examined after 24 hours does 
not of itself prove that deposition of antigen has 
ceased by that time, merely that the rate of removal is 
exceeding the rate of deposition. The urine analysis 
provided more insight into the speed at which the 
antigen is disposed of by the whole body. The vast 
excess of free over protein bound isotope indicated that 
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most of the antigen is rapidly degraded. ' The absence of 
detectable protein-bound iodine-125 in the urine after 4 
days indicated the latest point at which there was 
evidence of free antigen which could still bind-in the 
kidney. 2,3 Subsequent experiments were designed with 
this result in mind; it was assumed that any form of 
intervention applied four or more days after the last 
antigen dose could not influence the deposition of 
antigen in the kidney, but could only affect its 
removal. The very rapid removal of BSA from the 
glomeruli of the non-immune rats confirmed that the 
observed pattern of movement of cationic BSA was 
genuinely due to the immune complex glomerulonephritis 
and was not due to direct binding of the antigen to the 
anionic sites of the glomerulus. 
This experiment also provided information on the 
rate of removal of glomerular antigen and deposits which 
was of value in designing subsequent experiments. If an 
intervention at four days was to have a detectable 
1The standard diet on which the rats are fed contains ample 
iodine, so it is reasonable to assume that the rate of excretion 
of iodine-125 in the urine reflects the rate of its release from 
the BSA complex. Isotope excretion in the faeces was almost 
undetectable. 
2The greater sensitivity of detection of iodine-125 in the urine 
rather than the blood is presumably due to concentration of the 
urine, and the larger volumes available for study. 
3Iodine-125 is covalently bound to the protein, so it is 
reasonable to assume that release of free isotope only occurs when 
the whole molecule is degraded. 
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effect, the assessment of isotope and deposits in 
glomeruli must be delayed until a large proportion-of 
the antigen and deposits would normally have been 
removed, but not for so long that the amount remaining 
was too small to detect with any accuracy. Figure 16 
indicates that the continuing loss of antigen from 
glomeruli is quite rapid after 4 days, such that an 
increase or decrease in the rate should be detectable at 
two weeks. The deposit volumes show a less rapid fall, 
and it might be anticipated that even a proportionately 
large drop in the rate of removal of subepithelial 
deposits might , not be detectable at two weeks. 
Nevertheless, as the amounts of isotope and deposits in 
glomeruli after two weeks of recovery were quite small, 
it was decided to design subsequent experiments with 
division into experimental groups occurring after 4 days 
of recovery, and evaluation of the results after 14 
days. 
_.. .. _ 
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Figure 21. 
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It has been amply demonstrated that the status of 
the immune system can have a profound effect on the 
deposition of immune complex deposits in glomeruli. 
Having established a model and a protocol to investigate 
the removal of immune complex deposits, it seemed 
reasonable to investigate first the effects of crude 
stimulation or inhibition of the immune system. 
The observation that pre-immunization with Freund's 
complete adjuvant inhibited the development of 
glomerulonephritis (Chapter 4) raised the possibility 
that stimulation of the mononuclear phagocytes might 
enhance the removal of deposits from glomeruli, either 
by recruitment of activated macrophages, to the 
glomerulus or by activation of the resident population. 
The contrary effect, immunosuppression, might be 
achieved by administering large doses of 
corticosteroids. Finally, depletion of anti-BSA antibody 
might be achieved by administering native BSA, as large 
doses of this agent appeared to be non-nephritogenic, 
and antibodies raised against native or cationic BSA 
produced a single line of identity on Ouchterlony 
plates. It was appreciated that such crude' forms of 
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intervention would have-complex results; an excess of 
antigen, for example, has been shown of itself to 
facilitate deposit removal (Mannik & Striker 1980, 
Agodoa & Mannik 1987). This first experiment was 
therefore performed in the hope of identifying effects 
for further investigation, rather than with the 
intention of providing specific answers. 
Chronic serum sickness glomerulonephritis was 
induced in 40 rats by the methods already described, 
using seven intramuscular injections of radio-labeled 
cationic BSA over two weeks. The rats were left for four 
days after the last antigen injection then randomized to 
five, groups of eight rats each. The groups were treated 
as follows: 
1) Control. No treatment. 
2) A single subcutaneous injection of 0.5 ml of 
Freund's complete adjuvant and saline. 
3) A single subcutaneous injection of 0.5 ml of 
Freund's complete adjuvant with 1 mg of cationic 
BSA in saline. 
4) Daily subcutaneous injections of 5mg of 
prednisolone for ten days. 
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5) Daily intraperitoneal injection of 100mg of native 
BSA in saline for ten days. 
Ten days after the randomization the rats were 
killed and tissue samples taken and processed as 
described in Chapter 7 to assess the content of antigen 
and the volume fraction- öf 'deposits. In- addition, "' blood 
samples were taken for assessment' 'of the level of 
circulating anti-BSA antibody, using the ELISA technique 
described in Appendix 11. 
The mean amount of antigen in isolated glomeruli 
for each of the five groups at the end of the experiment 
is shown in Figure 22. It is reasonable to assume that 
at the time of randomization the glomeruli of all the 
groups of rats had the same mean antigen content. The 
mean antigen content at the end of the experiment 
therefore reflects the inverse of the average rate of 
antigen removal over the last ten days. It is evident 
that the administration of Freund's complete adjuvant, 
with or without added antigen, produced a significant 
decrease in the rate at which the antigen was being 
removed from the glomerulus (p < 0.01). Administration 
of prednisolone had no detectable effect, but the 
administration of native BSA produced a significant 
enhancement of the rate of antigen removal (p < 0.01). A 
similar result was seen after the analysis of whole 
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renal cortex (Fig. 23), although here the differences 
from the control group were statistically significant 
only in the groups given Freund's complete adjuvant with 
antigen or given native BSA. 
Figure 22 
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Figure 23 
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Morphometric analysis of deposit volume again 
provided similar results; rats give Freund's complete 
adjuvant and antigen were found to have a greater 
residual volume of mesangial deposits than controls, 
whereas the administration of native BSA enhanced the 
removal of mesangial deposits (p <0.05) 
.A significant 
difference could not be demonstrated after Freund's 
complete adjuvant alone, nor after prednisolone, and no 
differences could be demonstrated in the volume fraction 
of subepithelial deposits between any groups (Fig 24). 
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Figure 24 
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The antibody levels showed rather more variation 
within each group than did the glomerulus antigen load, 
and perhaps for this reason a statistically significant 
difference from the control group was only demonstrated 
in the groups given Freund's complete adjuvant and 
antigen or native BSA (Fig. 25) 
. 
The measurement of 
anti-BSA antibody was made in arbitrary units 
(comparable to a 'titre') because a standardized source 
of rat anti-BSA antibody was not available. However, the 
specificity and linearity of the assay were confirmed 
(see Appendix 11) and the measurements suffice to make 
comparisons between the groups. 
- 
119 
- 
Chapter 9 Altering the immune response 
Figure 25 
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This experiment was initiated with the suspicion 
that stimulation of the mononuclear phagocytes by 
Freund's complete adjuvant might enhance the removal of 
antigen from the glomerulus. The reverse was 
demonstrated. Since it was shown in Chapter 4 that rats 
which had received Freund's complete adjuvant did not 
develop glomerulonephritis, one must conclude that less 
antigen reached the glomeruli of those rats, rather than 
they were better able to remove it after deposition. 
- 
120 
- 
Control FCA FCA + Ag Pred. n-BSA 
Chapter 9 Altering the immune response 
If the administration of Freund's complete adjuvant 
did succeed in stimulating the glomerular phagocytes, it 
seems inherently unlikely that the presence of active 
macrophages would inhibit the removal of glomerular 
deposits. What other system might be responsible? There 
is a striking similarity in pattern between Figures 22 
and 25 which suggests the possibility of an inverse link 
between the rate of removal of a glomerular antigen and 
the plasma level of the corresponding antibody; that is, 
the presence of specific antibody might inhibit the 
removal of antigen from the glomerulus. Subsequent 
experiments were designed to investigate this hypothesis 
further. 
Another conclusion may be drawn from these results. 
As the antigen load per glomerulus and the volume 
fraction of deposits are known, and the mean glomerular 
volume can be readily measured (Aherne & Dunnill 1982), 
one can calculate a crude estimate of the ratio of 
antigen mass to deposit volume. Such a calculation makes 
several very dubious assumptions, such as the assumption 
that all the deposits have the same composition, and the 
assumption that all the antigen is within the deposits. 
Nevertheless the result is of interest. The ratio 
increases with the course of recovery, presumably due to 
continued accretion of materials other than antigen, but 
a figure of 1: 100 is typical. This indicates the paucity 
of antigen within the deposits, and supports the view 
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that some of the difficulty experienced 'in the 
identification of antigen in human glomerulonephritis 
may be due to 'masking' by other components. 
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To test directly the hypothesis that antibody 
against BSA inhibits the removal of BSA deposited in the 
glomerulus, passive immunization with rat anti-BSA 
antibody was employed. 
To produce the anti-BSA immunoglobulin, seven adult 
(over 250g) male Wistar rats were each given two 
subcutaneous injections of 1mg of cationic BSA in 0.25m1 
of saline, emulsified with 0.25m1 of Freund's complete 
adjuvant, three weeks apart. Two weeks after the second 
dose the rats were killed by exsanguination under 
anaesthetic. To maximize the yield of serum, blood was 
collected from a cannula in the abdominal aorta while 
5m1 of saline was infused into the inferior vena cava. 
Seven non-immune rats of similar weight 'were also 
exsanguinated to provide control serum. The blood was 
allowed to clot, the serum collected and the two groups 
pooled. A gamma globulin fraction of each was prepared 
by ammonium sulphate precipitation (Appendix 12). The 
precipitates were re-dissolved, dialysed, centrifuged 
and passed through a 0.2µm filter to remove particulate 
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matter, lyophilized and stored at 
-20°C. A simple ELISA 
assay was used to assess the ability of the immune 
globulin to bind to BSA; compared to control globulin, 
activity was still present at a titre of 100,000 
(Appendix 11). 
Cationic BSA chronic -serum sicknes's was induced'in' 
20 rats by the standard protocol. Four days after the 
last antigen injection the rats were divided into two 
groups of ten. Rats in one group received a single 
intraperitoneal injection of 75 mg of non-immune rat 
gamma globulin in 0.75m1 of saline, while the other 
group received 75mg of anti-BSA rat gamma globulin. The 
rats were all killed ten days later and tissues were 
sampled as described in Chapter 7 for the assessment of 
antigen content and deposit volume fraction. 
Assessment of the mean amount of antigen per 
glomerulus at the end of the experiment showed that the 
control group had a mean of 76pg of antigen per 
glomerulus (95% confidence limits ± 10 pg), whereas the 
group which had received immune globulin had a mean of 
107pg per glomerulus (±17pg). The administration of 
anti-BSA antibody had therefore inhibited the removal of 
cationic BSA from the glomerulus (t-test: p<0.005). 
The amount of antigen remaining in whole tissues at 
the end of the experiment is shown in Figure 26. This 
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confirmed that passive immunization inhibits the removal 
of antigen from the renal cortex- (p < 0.05) 
, 
though' a 
significant effect was not found in any of the other 
tissues studied. 
Figure 26 
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Morphometric evaluation of the volume fraction of 
the glomerular deposits showed that the rats which had 
received anti-BSA globulin had significantly more 
mesangial deposits at the end of the experiment than the 
control group (Fig 27: p<0.001). A similar but smaller 
result is suggested for the subepithelial deposits, but 
the difference did not reach statistical significance 
(t-test: p=0.104). 
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Figure 27 
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These results confirmed that specific 
immunoglobulin can inhibit the removal of antigen and 
mesangial electron dense deposits from the glomerulus. 
The significance of this will be discussed later, but it 
is worth noting here that the opposite view is widely 
held (Pusey et al. 1988), without supporting evidence, 
although there are some reports in the literature which 
indirectly support my findings (Goode et al. 1985). 
It may be noted that the mean glomerular antigen 
content of the control group after ten days of recovery 
differed in this experiment from the last, despite the 
fact that the control groups were apparently treated in 
- 
126 
- 
Chapter 10 Passive immunization 
identical manner. This observation was repeated in 
subsequent experiments. There is no clear explanation 
for this. The largest differences were seen when a 
different batch of cationic BSA was used; the 
cationization reaction is somewhat capricious, so this 
may be due to minor differences in the pI between 
batches, even though batches with a pI which was 
detectably different by isoelectric focussing were 
discarded. This would not influence the results within 
one experiment, as the BSA was always pooled before the 
experiment started. Some variation in the results of the 
control groups of different experiments was noticed even 
where the same batch of cationic BSA was used. This 
could be due to variation in the immunization protocol 
(e. g. the degree of emulsification of the adjuvant) or 
to different batches of rats. This effect was not 
considered to have any influence on the conclusions 
because, as the results indicate, the degree of 
variation within each group was quite small. It does 
provide grounds for excluding historical control groups. 
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The major known constituents of most electron dense 
deposits are antigen, antibody and complement 
components. After having demonstrated the influence of 
one component, antibody, on the rate of removal of the 
deposits, it was a logical progression to test another, 
complement. Depletion of plasma complement was achieved 
by administration of cobra venom factor (CVF). 
Chronic serum sickness glomerulonephritis was 
induced as before in 20 male Wistar rats, using cationic 
BSA over two weeks. Four days after the last antigen 
dose the rats were divided into two groups of ten. The 
animals in one group received 25µg. of CVF (Sigma) in 
O. lml of saline by intraperitoneal injection every three 
days for the following ten days. The--control group 
received no treatment. To confirm that the CVF of itself 
did not produce glomerular deposits-. or proteinuria, 
three normal, non-immune, 
- 
age-matchedrats were also 
given CVF by the same regimen. Blood samples were taken 
daily from the tail tip and. serum haemolytic complement 
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was estimated by a simple hwmolytic plate assay 
(Appendix 13). 
At the end of this period the rats were killed and 
tissues sampled by the routine method. 
Complement activity was not detectable by hwmolytic 
plate assay in any of the rats receiving CVF. Figure 28 
shows one of the plates produced at the end of the ten 
day period of decomplementation; there are clear zones 
of h&molysis around the wells containing serum from the 
control rats, whereas serum from rats given CVF has 
produced no haemolysis. 
Figure 28. H&-molytic plate assay for complement. Samples 
on the left (I to L) are from rats with chronic serum 
sickness alone. Those on the right (U to X) are from 
rats which also received CVF. Samples taken on the last 
day of the experiment. Sample X was partly h&molysed. 
o o<V 
CON'. CVF 
w 
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The mean glomerular antigen content of the control 
group was 123pg (95% limits ± 20pg) per glomerulus. In 
contrast to the results after passive immunization 
described in the previous chapter, the rats which had 
received CVF had more antigen remaining in their 
glomeruli at the end of the experiment: 205pg (± 30pg) 
per glomerulus. This is a highly significant difference; 
p<0.001 by t test. It indicates that the presence of 
plasma complement enhanced the removal of glomerular 
antigen. If whole renal cortex was assessed, the same 
result was found (Fig. 29). The amounts of antigen 
remaining in. liver, spleen and lung all appeared to show 
minor alterations in the same direction, but the 
differences were not statistically significant. 
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Figure 29 
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Morphometric analysis of the volume fraction of 
deposits in the glomeruli of these rats indicated that 
the rate of removal of both subepithelial and mesangial 
deposits is reduced in the absence of complement 
(Fig. 30). 
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Figure 30 
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Administration of cobra venom factor inhibits the 
removal of antigen from glomeruli and of both 
subepithelial and mesangial electron dense deposits. The 
role of complement in glomerulonephritis is usually 
considered to be deleterious, and proteinuria is 
abolished by the elimination of complement in many 
animal models. There is a single report in the 
literature indicating that complement depletion inhibits 
antigen removal in acute serum sickness in the rabbit 
(Bartolotti and Peters 1978). More recent work in this 
field has concentrated on the in vitro demonstration of 
the ability of the complement system to inhibit immune 
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complex aggregation and to dissolve immune complexes 
once formed (Schifferli et al. 1980,1986). The effect 
described here is presumably an in vivo reflection of 
this capability. 
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The inhibitory effect of decomplementation with 
cobra venom factor appeared to be large. Comparison of 
the difference between the control and experimental 
groups with the uninterrupted rate of antigen removal 
shown in Chapter 8 suggested that the elimination of 
plasma complement might actually have caused cessation 
of removal of antigen, but as has already been noted, 
comparisons between groups of experimental animals 
studied at different times are°not valid with this 
model. A further experiment was therefore performed to 
assess changes in the rate of antigen removal with or 
without circulating complement. 
Chronic serum sickness glomerulonephritis was 
induced in 32 rats by the standard protocol, but instead 
of allowing 14 days of recovery, small groups of rats 
were killed at intervals after the last antigen dose. 
Four were killed 24 hours after the last dose and four 
at four days. At this point the remaining 24 rats were 
divided into two groups. One group was treated with CVF, 
0.25µg, every three days as in the last experiment. Four 
rats from each group were killed 3,6 and 10 days after 
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the start of CVF treatment. Tail-tip blood samples were 
taken daily after the start of CVF treatment and 
complement activity assessed by haemolytic plate assay as 
before. 
Samples of-tissue were taken as before, except that 
morphometric analysis of deposit volume was not 
attempted with these small groups of animals, and urine 
samples were taken by bladder puncture for the 
assessment of proteinuria (Sulphosalicylic acid method: 
Appendix 9). 
Sequential assessment of the glomerular antigen 
load of rats recovering from chronic serum sickness 
glomerulonephritis provided the results shown in 
Figure 31. The elimination of plasma complement had very 
little effect on the rate of antigen 
-elimination 
for a 
few days, but after one week elimination appeared to 
have virtually ceased in the CVF group. Not 
surprisingly, the evaluation of whole renal cortex 
showed the same effect, and again liver, spleen and lung 
showed little change (Fig. 32). 
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Figure 31 
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The level-of proteinuria induced by this model has 
been shown to be more variable than the glomerulus 
antigen content, but nevertheless the rats given CVF 
during the 'recovery phase were found to have 
significantly less protein in the urine than the control 
group (Fig. 33). 
Figure 33 
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The haemolytic plate assays again confirmed 
successful complete elimination of complement activity 
during the whole of the ten day period of CVF treatment. 
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The elimination of complement... was found to have a 
profound effect on the rate of antigen removal, but not 
an immediate one. One may suggest that perhaps activated 
C3 bound in the glomerulus continues to have an effect 
for a few days, but our understanding of the mechanism 
by which complement dissolves immune complexes is too 
incomplete to press this hypothesis further. It is 
interesting to note that rats treated with CVF have less 
protein in the urine, despite having more antigen and 
larger deposits in their glomeruli. 
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Are mononuclear phagocytes involved? 
If the elimination of complement causes cessation 
of removal of antigen from the glomerulus, one might 
suggest that any other mechanisms of antigen removal 
must work in co-operation with and be dependent upon 
complement. Resident glomerular mononuclear phagocytes 
have been held to be responsible for antigen removal; if 
so, does their action require 'opsonization' by 
complement? There is good evidence for the involvement 
of glomerular macrophages in the processing of immune 
complexes and other particulate matter as it arrives at 
the glomerulus, but direct evidence of the involvement 
of macrophages in the removal of established, 
morphologically identifiable deposits is°not available. 
The results of experiments using anti-macrophage serum 
were discussed in Chapter 3; they do not appear to 
support a role for macrophages. Furthermore, 
- 
the 
observation that the administration of Freund's complete 
adjuvant inhibits the removal of deposits (vide supra) 
suggests that macrophages are probably not involved in 
this process. 
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To investigate this question further, methods were 
required to stimulate or inhibit macrophage activity. 
Three agents were used, selected on the basis of their 
likely efficacy and selectivity, and their availability. 
1) Polyvinyl alcohol (PVA). This inert polymer has 
recently been shown to accumulate in the glomerulus 
after subcutaneous injection, causing an increase 
in, the activity and number of glomerular 
macrophages (Seiler et al. 1983) with very little 
effect on glomerular blood flow or filtration rate 
(Sterzel et al. 1983). The uptake into the 
glomerulus of particulate tracers such as colloidal 
carbon or iron dextran is consequently increased 
(Mauer et al. 1979, Seiler et al. 1986). 
2) Puromycin aminonucleoside (PAN). This agent is 
widely used to induce a model of minimal change 
nephrotic syndrome. It probably has a toxic effect 
on glomerular epithelial cells, but in addition it 
appears to increase the numbers and activity of 
mesangial phagocytic cells (Schreiner et al. 1984), 
with increased trapping of particulate tracers 
(Grond & Elema 1981, Hoyer et al. 1976). If 
mesangial macrophages remove mesangial deposits, 
one might therefore expect the administration of 
PAN to enhance their removal. Macrophages do not 
normally gain access to subepithelial deposits, but 
if the epithelial cells are involved in the removal 
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of such deposits the use of Puromycin 
aminonucleoside might alter the rate of their 
elimination, as assessed by morphometry. 
3) Colchicine. This drug is known to act by blocking 
microtubular function (Borisy & Taylor 1967), and 
has been used in the past to inhibit macrophage 
activity (Von Figura et al. 1878, Cain et al. 
1983); it appears to inhibit their motility and 
phagocytic function. Colchicine also alters the 
shape of glomerular podocytes in vitro (Andrews 
1981) and decreases the proteinuria in Heymann 
nephritis (Milner et al. 1987). The problem with 
its use is the narrow dose range between 
therapeutic efficacy and toxicity. In this study it 
proved impossible to detect any change in the 
glomeruli of rats given colchicine, so although the 
results for this group are presented, no 
conclusions are drawn from them. 
Chronic serum sickness glomerulonephritis was 
induced in 32 male Wistar rats, by the standard 
protocol. Four days after the last antigen dose, the 
rats were divided into four groups of eight, and treated 
as follows: 
1) Control. No treatment. 
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2) Polyvinyl alcohol (Sigma: M. W. 40,000 to 60,000), 
lml of a 5% solution in saline by daily 
subcutaneous injection for ten days. 
3) Puromycin aminonucleoside 100mg by a single 
intraperitoneal injection. 
4) Colchicine 20µg in water, by daily gavage for ten 
days. 
To confirm alterations in glomerular macrophage 
function the rats received an intravenous injection of 
100 mg of iron dextran (Imferon®) 24 hours before 
sacrifice. 
At the end of the ten day intervention period the 
rats were killed and samples taken according to the 
standard protocol. In addition, blood samples were taken 
from the control and Puromycin groups to assess the 
severity of the nephrotic syndrome. Samples of frozen 
renal cortex were also taken. 
An attempt was made to assess the numbers of 
glomerular macrophages using an immunoperoxidase 
technique on frozen sections with the monoclonal 
antibodies 0X3 and 0X4 (Sera-lab), which recognize rat 
macrophages. This was not successful because the 
secondary antibody (rabbit anti-mouse IgG) bound to the 
rat IgG which was in the glomeruli as a result of the 
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glomerulonephritis, causing heavy granular staining even 
in control sections, and masking any cellular staining. 
Fortunately other methods were available to confirm the 
effect of the treatment given. In the case of polyvinyl 
alcohol the morphological changes were obvious 
(Fig. 34). Globules of amorphous material (PVA) 
accumulated in the mesangium; on electron microscopy 
these were seen to be mainly inside vacuoles in cells 
with the morphological characteristics of macrophages. 
Puromycin aminonucleoside caused the nephrotic syndrome 
to become considerably worse (Table 6). Very little of 
the injected iron dextran had localized in the 
glomeruli, but a Perl's Prussian Blue stain of paraffin 
sections of kidney showed patchy blue staining of some 
of the glomeruli of rats given PAN, whereas iron could 
not be detected in any of the glomeruli of the control 
group. Colchicine did not produce any detectable effect. 
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Figure 34. A glomerulus from a rat which had received 
PVA, showing an influx of PVA-laden foamy macrophages. 
H&E, x 1,200. 
Table 6. Serum evidence of enhancement of nephrotic 
syndrome due to Puromycin aminonucleoside (Mean ± 95% 
confidence limits) 
Albumin Cholesterol 
(mg/ml) (mmol/1) 
Normal rats 
(Data from Ch. 5) 
Control 
(Chronic serum sickness) 
Puromycin aminonucleoside 
(CSS + PAN) 
35.8 ± 1.66 1.62 ± 0.175 
25 ± 3.62 3.7 ± 1.47 
17.9 ± 3.16 11.5 ± 1.65 
p<0.01 cf chronic serum 
sickness alone 
A significant difference could not be demonstrated 
between the amount of antigen in the glomeruli of any of 
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the experimental groups (Fig. 35). Analysis of whole 
renal -cortex provided the same `Sresult (Fig. 36) . The 
glomeruli from rats which had received PVA were found to 
be increased in volume by a factor-of 1.25 compared with 
the control group; after adjustment of the volume 
fractions of the deposits by this amount as described in 
Chapter 7, a difference could not be demonstrated 
between any of the groups (Fig. 37). 
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Figure 36 
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The results of this experiment provide further 
support for the theory that glomerular phagocytes do not 
contribute significantly to the removal of established 
glomerular electron dense deposits or the antigen which 
they contain. Unfortunately the matter is still not 
resolved, as the results are negative; they fail to 
demonstrate a difference, but they do not prove that a 
small difference does not exist. The evidence relating 
to this question, and potential ways of resolving it, 
will be considered further in the Discussion. 
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The importance of the electrical charge of an 
antigen in determining its localization in the 
glomerulus has already been discussed. Neutralization of 
the glomerular charge by simultaneous infusion 
protamine, a non-antigenic cationic substance, has been 
reported to influence this localization (Adler et al. 
1983b) 
. 
It is obviously of interest to investigate 
whether such interference can alter the rate of removal 
of antigen and deposits. This question has already been 
addressed using an acute, passive form of serum 
sickness. Gauthier and Mannik (1986) reported that an 
infusion of protamine would enhance the removal of 
cationic immune complexes from the glomerulus only if 
given within an hour of localization of the complexes. 
After that time no effect was detectable, indicating a 
change in the nature of binding of the complexes in the 
glomerulus, and suggesting that charge interactions are 
only of importance in the early stages of deposit 
development. However, the model used in that experiment 
is very different to the chronic serum sickness model of 
these investigations. In view of the considerable 
potential for therapeutic intervention in Man if a 
charge effect could be demonstrated, -it was decided to 
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proceed with an attempt to influence deposit removal by 
the chronic administration of protamine (cationic), 
polyethyleneimine (PEI; cationic) or heparin (anionic). 
Chronic serum sickness glomerulonephritis was 
induced in 24 rats by the standard protocol, 
_. 
using seven 
10mg doses of radiolabelled cationic BSA. After four 
days of recovery the rats were divided into four groups 
and treated a follows: 
1) Control group. No further treatment. 
2) 500 units of heparin were given by 
intraperitoneal injection, twice daily (daily 
at weekend). 
3) 5mg of protamine was given by intraperitoneal 
injection, twice daily (daily at weekend). 
4) 0.4m1 of a 2% solution of PEI (Polysciences) 
was given daily by tail vein injection. 
After ten days of this treatment the rats were 
killed according to the standard protocol. 
The administration of heparin enhanced the removal 
of glomerular antigen (Fig. 38). This effect was 
confirmed by analysis of whole tissues (Fig. 39), but 
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measurement of deposit volume fraction did not detect 
any significant differences (Fig. 40). 
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An attempt was made to detect alterations in the 
charge densities in the glomeruli. Staining of renal 
cortex with the cationic dyes Alcian Blue or colloidal 
iron at light microscope level (Appendix 14) failed to 
demonstrate any convincing differences between the 
glomeruli of the experimental and control groups. At 
E. M. level, staining of anionic sites by immersion of 
tissue in polyethyleneimine (Appendix 15) also showed no 
differences in the first three groups. Glomerular 
anionic sites can also be demonstrated by in vivo 
injection of PEI, and staining (using phosphotungstic 
acid; Appendix 15) of tissues from the rats which had 
been given intravenous PEI did indeed show the anionic 
sites, confirming that the PEI given was indeed reaching 
the glomerulus (Fig. 41). 
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Figure 41. Glomerular basement membrane of a rat treated 
with PEI. The anionic sites of the basement membrane are 
demonstrated as black dots, confirming that the PEI was 
reaching and adhering to the glomerular basement 
membranes. Transmission electron micrograph: PEI given 
in vivo, tissue immersed in 2% phosphotungstic acid, 
then processed routinely. x 80,000. 
It is difficult to know what weight should be 
attached to these findings in view of the absence of 
evidence that the charged molecules administered were 
producing any alteration in the glomerulus. A search of 
the literature failed to provide any guidance for 
appropriate dosage for the drugs when given over a 
period of several days. The dose of heparin given was 
approximately twice that necessary to cause complete 
- 
153 
- 
Chapter 13 Charged molecules 
anticoagulation of blood samples-taken two hours after 
administration. Complications due to spontaneous 
haemorrhage were not seen. The dose of protamine was 
sufficient to neutralize an equal amount of heparin, had 
the two been administered to the same animal. The dose 
of PEI was half of an approximate LD50 for this 
substance, determined before the experiment. It is 
sixteen times the amount given intravenously to produce 
ultrastructural staining of the glomerular anionic sites 
(Schurer et al. 1978); doses of this magnitude have been 
shown to penetrate the full thickness of the basement 
membrane and bind to anionic sites on the epithelial 
cells (Andrews & Bates 1985). In the light of this, the 
absence of any alteration in deposit removal in the 
group given PEI does give some support to the claim that 
charge interactions are not of great importance after 
the initial binding of antigen (Gauthier & Mannik 1986). 
Polyethyleneimine is cationic, as is the antigen. 
Heparin is anionic; the mechanism by which heparin 
enhances the removal of antigen from the glomerulus 
could perhaps be a simple charge effect, but it is more 
likely to be related to the complex biological effects 
of this substance. This will be considered further in 
the Discussion. 
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Haemodynamic changes can profoundly alter the 
function and indeed the structure of the glomerulus. A 
wealth-of evidence can be quoted to support this point; 
it is particularly relevant to note that stenosis of one 
renal artery, with consequent diminution in blood flow 
and glomerular filtration rate (GFR), provides 
protection for that kidney against the development of 
immune complex glomerulonephritis (Germuth et al. 1967, 
Salyer & Salyer 1974). Other evidence of the influence 
of haemodynamic factors has been reviewed in Chapter 2. 
It follows that a decrease in the blood supply must 
either reduce the rate of deposition of immune complexes 
or facilitate their removal. It seems likely that a 
decreased blood flow would decrease delivery of the 
components of the deposits, but this may be simplistic, 
and other effects are not excluded. The foregoing work 
suggests that plasma complement is an important agent in 
the removal of deposits; could the rate of delivery of 
complement influence the rate of removal? To investigate 
this area, two experiments were performed in which the 
GFR of one group of rats was altered during the course 
of recovery from chronic serum sickness 
glomerulonephritis. This was achieved by unilateral 
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nephrectomy in one experiment, and extreme alteration in 
the salt and protein content of the diet in the other. 
Pharmacologic methods of altering the GFR were avoided. 
The GFR of each rat was measured using an accepted 
modification of the 51Cr-EDTA method, as described by 
Layzell and Miller (1975: Appendix 16). 
Unilateral nephrectomy. Chronic serum sickness 
glomerulonephritis was induced in 25 rats by the 
standard protocol. After four days of recovery the rats 
were divided into two groups. All were anesthetized 
(Hypnorm® and diazepam). Twelve rats received a sham 
operation in which the abdomen was opened in the 
midline, the left kidney was briefly palpated, and the 
abdominal wall was closed in two layers. A left 
nephrectomy was performed on the remaining 13 rats. All 
the animals made an uneventful recovery and were killed 
ten days later for routine tissue sampling. 
Diet. Two special rat diets were obtained from 
Special Diet Services (Stepfield, Witham, Essex). Both 
had a low salt content; one (designated LP) had a 
protein content of less than 2.5%, the other (designated 
HP) had a protein content of 40%, made up of casein, 
soya and egg protein. Chronic serum sickness 
glomerulonephritis was induced in 32 rats by the 
standard protocol. After four days of recovery the rats 
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were divided into four groups of eight rats each and 
provided with food and water as follows: 
Table 7 
Food Drink 
LP, LS LP diet Water 
LP, HS LP diet 1.8% saline 
HP, LS HP diet Water 
HP, HS HP diet 1.8% saline 
After ten days of this regimen, the rats were 
killed and tissues sampled. 
In both these experiments the procedure at 
sacrifice was modified to permit measurement of the 
glomerular filtration rate, which was achieved by the 
51Cr-EDTA method. The rats were first given a small dose 
of. anaesthetic (0. lml of Hypnorm i. m. ) to facilitate the 
accurate intravenous injection of O. lml (1Oµ. Ci) of 51Cr- 
EDTA (Amersham); the time of the injection was noted. 
Approximately an hour later a full dose of anaesthetic 
was given (Hypnorm and diazepam) and the abdomen opened. 
After the sample of renal cortex had been removed for 
electron microscopy, a blood sample was taken from the 
inferior vena cava and 500µl of heparinized-plasma was 
submitted to the gamma counter. The weight of each rat 
and the time of blood sampling were also noted, and the 
GFR was calculated from these data (Appendix 16). 
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Results 
Unilateral nephrectomy produced the expected rise 
in the GFR of the remaining kidney, as'shown in Table 8. 
Table 8. Single kidney GFR (ml/min) 
GFR 95% limits 
Sham operated 0.58 0.04 
Unilateral nephrectomy 0.95 0.06 
p<0.001 
Alteration in diet produced smaller changes in GFR. 
Because of this the results were pooled to give groups 
of 16 rats each, receiving low salt (LP, LS & HP, LS) 
, 
high salt (LP, HS & HP, HS) 
, 
low protein (LP, LS & LP, HS) 
or high protein (HP, LS & HP, HS) 
. 
The results of this 
manoeuvre are shown in Figure 42. A high salt intake 
produced a significantly lower glomerular filtration 
rate. The high protein diet produced only a slightly 
higher mean GFR; the difference was not statistically 
significant. It should also be noted that the different 
groups had significantly different mean body weights at 
the_ end of the experiment; the high protein group 
weighed more (261g vs 243g; p<0.05) as did the low 
salt group (2638 vs 241g; p<0.05), indicating that the 
high salt intake had not caused increased oedema. 
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Figure 42 
Glomerular filtration rates 
Effect of diet 2'p<0.001 
0 
Low salt High salt Low High 
protein protein 
The 'results of the standard investigations are 
shown in Figures 43 to 46. None of the manoeuvres to 
alter the GFR, whether successful or not, produced any 
detectable differences in the parameters measured, with 
the exception of a lower antigen content of whole renal 
cortex in the group receiving a high salt diet 
(Fig. 46). This difference was just significant at p= 
0.05, but in view of the absence of a parallel effect on 
the antigen content of isolated glomeruli (Fig. 44) it 
is likely that this result has either arisen by chance 
or relates to antigen in renal structures other than the 
glomeruli. 
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Figure 43 
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Figure 45 
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Unilateral nephrectomy produced the expected large 
increase in single kidney GFR (Provoost & Molenaar 
1980). The'high protein diet produced a higher mean GFR, 
but the results were not significantly different, so 
these groups must be discounted. It is perhaps 
surprising that a high salt diet produced a lower GFR. 
This is not an artefact of the method of measurement, 
caused by fluid retention, as the high salt group 
weighed slightly less than the low salt group. It may 
relate to the overall state of health of the animals, 
which appeared to be less good at the end of the 
experiment in the high salt group. 
Within the range of alteration achieved, this study 
provides no evidence that glomerular hmmodynamics 
influence the rate of removal-of antigen from the 
glomerulus. 
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DISCUSSION 
This work has attempted to elucidate some of the 
mechanisms involved in the removal-of immune complex 
deposits from the glomeruli of rats with chronic serum 
sickness glomerulonephritis. It is appropriate to 
examine some of the problems which such-a study must 
acknowledge. 
In studying the removal of deposits, one is 
investigating a system which is. poorly understood acting 
upon a material of unknown and variable composition. It 
is not necessary to stress here how little is known 
about the functional capabilities of the various cells 
of the glomerulus, but it is worth emphasizing the 
heterogeneous nature of the deposits. The causative 
antigen is rarely known in human disease, but even where 
the antigen is known, the associated antibodies are of 
varying classes and affinities. Complement components 
may bind by classical or alternative pathway. The 
proportions of these three main components vary; in some 
diseases, such as mesangiocapillary glomerulonephritis, 
antibody may occasionally be almost undetectable. The 
proportions may change with time, as is shown by the 
disproportionate changes in 'glomerular antigen content 
and deposit volume fraction during recovery from chronic 
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serum sickness reported in Chapter 8. In" most 
glomerulonephritides no other major constituents of the 
deposits are known. This thesis has provided crude 
evidence that the proportional content of antigen in the 
deposits induced in this model is very small, despite 
large doses of antigen. The proportional content of 
antibody and complement is unknown, and it is likely 
that'other constituents are incorporated into and modify 
the properties of the deposits. Other components of the 
plasma may be included. Epithelial, endothelial and 
intrinsic mesangial cells all synthesize basement 
membrane components, so it is likely that these 
substances will be enmeshed in the deposits as they 
grow. In the chronic serum sickness model described in 
this thesis it can be demonstrated that the anionic 
layer of the lamina rara externa re-forms over 
subepithelial deposits within four weeks of their 
formation (Furness & Turner 1987), and the manner in 
which the deposits of human membranous 
glomerulonephritis become surrounded by basement 
membrane material is well known. It is likely that such 
surface changes as these also influence the mechanisms 
which remove the deposits. Deposits at different sites 
in the glomerulus are likely to have different 
characteristics and are certainly exposed to different 
conditions which might cause their removal. These 
conditions will also vary in different diseases; it 
cannot be assumed that mechanisms which lead to deposit 
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removal in acute proliferative glomerulonephritis will 
be of significance in, say, membranous 
glomerulonephritis. 
In view of these problems, what justification can 
be given for an attempt to elucidate the mechanisms of 
deposit removal in an artificial form of 
glomerulonephritis in the rat? I would propose the 
following arguments. 
1) Despite the differences, the protean forms of 
immune-complex glomerulonephritis have many 
features in common, the most notable being the 
near-universal presence of antibody, complement and 
antigen (if identifiable), and the morphological 
similarities of the deposits formed in different 
diseases, as visualized by electron microscopy. 
These similarities suggest that though the diseases 
differ, similarities in the properties of the 
deposits may exist, and may even be necessary for 
their formation and persistence. This argument 
provides hope that features of an artificial model 
may be relevant to at least some forms of 
spontaneous human disease. 
2) There are differences in the conditions at the 
various locations at which deposits may develop, 
but these locations number only three; 
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subepithelial, subendothelial and mesangial. 
-Two of 
these are represented in the model used in this 
work, and the recognition that their properties may 
differ led to the attempt to distinguish between 
the two by morphometric analysis of their volume 
fractions. Subendothelial deposits are not seen in 
this model, but they are the least common form of 
deposit inhuman glomerulonephritis. 
3) Differences in the conditions in the glomerulus in 
different forms of glomerulonephritis lie mainly in 
the cells infiltrating the glomerulus and in 
haemodynamic alterations. Differences in the 
composition of the plasma perfusing the glomerulus 
are probably slight. If a glomerulus is capable of 
recovery from an immunological insult, that is, if 
crescents have not formed and the glomerulus is not 
sclerosed, then subepithelial deposits (which are 
probably most relevant to glomerular dysfunction) 
are separated by the glomerular basement membrane 
from the infiltrating cells, and are in contact 
only with the podocytes and any material which can 
cross the filtration barrier. This point is valid 
irrespective of disease or species, and again 
argues for a wide applicability of any removal 
mechanism, at least in the subepithelial location. 
4) The final argument is one of practical necessity. 
Most forms of human glomerulonephritis are not 
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susceptible to therapeutic intervention at present. 
Any improvement in our understanding of the rural 
mechanisms of deposit removal may permit the 
manipulation of those mechanisms to the benefit of 
patients with glomerulonephritis. Experiments with 
relevant animal models provide the best hope for 
gaining insight into such complex systems. The 
arguments that the model used here is appropriate 
for this purpose were proposed in Chapter 4. 
The problem may be approached by considering what 
mechanisms could in theory be influencing the removal of 
deposits, then assessing the evidence for each. This is 
best done initially according to the location of the 
deposit in the glomerulus. 
Mesangial deposits are` exposed to' all the 
soluble constituents of plasma, irrespective of 
molecular size. This is evident from the'ease with which 
particulate tracers pass from the capillary into the 
mesangial channels (Farquhar & Palade 1961, Elema et al. 
1976). For the same reason, soluble substances 
administered therapeutically are likely to gain ready 
access. Hmmodynamic changes induced by the disease'or by 
therapy may alter the rate of delivery of"soluble 
material. Mesangial deposits are exposed to the 
intrinsic mesangial cells, which probably have some 
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phagocytic capacity (Sterzel et al. 1982) but appear to 
have a mainly structural and contractile role. The cells 
which are of most interest in this area are clearly the 
mesangial macrophages, which are normally present in 
small numbers (Schreiner et al. 1981, Schreiner & Unanue 
1984, Gurner et al. 1986) and whose numbers and activity 
can be considerably enhanced by various forms of 
glomerular damage. 
The situation of subepithelial deposits is 
clearly different. Soluble constituents of the plasma 
can only gain access by crossing the basement membrane. 
The fact that IgM can localize in this space (at least 
in diseased glomeruli) indicates that this is not as 
formidable a barrier as a study of normal glomerular 
function might suggest, but the rate of access of a 
relevant substance might be limited. The glomerular 
basement membrane is probably more important in limiting 
the access of cells. The podocytes are in intimate 
contact with subepithelial deposits, but there is no 
evidence that these highly specialized cells influence 
deposit removal. No other cell type has ready access to 
the subepithelial deposits unless the glomerulus is very 
severely damaged. One might suggest that the appearance 
of macrophages in crescents represents an ineffective 
attempt to remove the deposits; but as the development 
of crescents appears to relate to the presence of fibrin 
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in the urinary space (Silva et al. 1984) rather than the 
presence of deposits, this does not seem likely. 
Subendothelial deposits are subject to 
conditions which resemble those of mesangial deposits: 
ready access to plasma constituents and macrophages. It 
has been suggested that the process of mesangial 
interposition seen in mesangiocapillary 
glomerulonephritis represents an attempt by the 
mesangial cells to reach and dissolve the deposits. In 
addition these deposits are exposed to the endothelial 
cells, and to circulating neutrophils. 
A final possibility has received very little 
attention; the basement membrane itself. It is surely no 
coincidence that deposits at all locations (including 
most mesangial deposits) can be shown to be in 
apposition to a basement membrane. It has been suggested 
that these structures contain up to fifty separate 
components, of which only a handful have been isolated 
(Timpl et al. 1984). The properties of the basement 
membrane presumably influence the initial accumulation 
of deposits, but the possibility that some of the 
unknown constituents are involved in deposit removal has 
not been studied. 
The evidence provided in this thesis will now be 
related to the theoretical possibilities. 
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The three known constituents of the deposits in the 
" model studied are all derived from the plasma, and these 
will be considered first. 
Antigen. The Ouchterlony immunodiffusion plates 
indicated that antibody raised against cationic BSA 
recognized cationic or native BSA with a line of 
identity. The excess of native BSA given in the 
experiment described in Chapter 9 would therefore 
interact with anti-BSA antibody in the circulation or 
the glomerulus just as would cationic BSA, but without 
the tendency (at such high doses) to produce further 
glomerular deposition. The administration of excess 
antigen has been shown in a chronic mouse model of 
glomerulonephritis to enhance antigen removal 
(Haakenstad et al. 1983), and this effect was confirmed 
here. The mechanism is believed to involve disruption of 
the antigen-antibody lattice, as can be demonstrated by 
addition of excess antigen to immune complexes generated 
in vitro. Mannik and Striker (1980) confirmed that this 
can happen in an acute, passive serum sickness model 
which was not complicated by involvement of the-host's 
own immune system., The apparent limitation of this 
effect to mesangial deposits (described in the above 
reports and in this thesis) may be due to limitation of 
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access of antigen to the subepithelial deposits, as an 
excess of cationic antigen has been claimed to remove 
acute subepithelial deposits (Agodoa & Mannik 1987). But 
is this lattice disruption theory necessarily relevant 
to the removal of long-standing deposits? Penner et al. 
(1979) found that antigen-mediated dissolution of 
deposits from tissue sections became less effective as 
the deposits became older. Haakenstad et al. (1983) 
reported a comparable effect in vivo. The deposits 
studied in this thesis were found to have an approximate 
mean deposit volume : antigen mass ratio of 100 : 1, 
which is presumably much higher than the pre-formed 
complexes of passive serum sickness. In the model 
studied here, the administration of a large antigen 
excess produces a considerable depletion of specific 
circulating antibody. The results described here 
indicate that this effect may provide an additional 
mechanism of enhancing deposit removal. 
- 
Antibody. The inability of cationic BSA to persist 
in the glomeruli of non-immune rats indicates that 
specific antibody is necessary for the initial formation 
of the deposits. The results described in Chapter 9 
suggest that the presence of specific antibody also 
inhibits the removal of mesangial deposits; this is 
confirmed by the results of passive immunization in 
Chapter 10. The results suggest but do not prove a 
similar effect on subepithc. 
-'ial deposits; the negative 
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result is certainly not proven, as the slower natural 
rate of removal of the subepithelial deposits makes the 
morphometric detection of changes more difficult. In 
some respects these results are not surprising, as the 
deposits are generally believed to grow by surface 
accretion of material, including antibody. Goode et. al. 
(1985) showed that if BSA-coated latex beads are caused 
to lodge in the mesangium, the administration of anti- 
BSA antibody inhibits their, removal, a phenomenon which 
parallels the effect of antibody described here. 
Nevertheless it has been claimed, by analogy with the 
effect of excess antigen, that specific antibody 
enhances the removal of the 
- 
deposits (Pusey et al. 
1988). This is clearly not the case, but it is very 
different from the effect of antibody in other 
situations, where opsonization and enhanced removal of 
the antigen is the usual effect of the binding of 
antibody. The deleterious effect of specific antibody 
provides some theoretical justification for therapeutic 
attempts to reduce the titre in cases of human disease, 
but the benefits of the non-specific forms of 
immunosuppression which are currently available are 
doubtful in most forms of glomerulonephritis (Achiari- 
Rey & Pollack 1982, Glassock 1982). 
Complement. There is an extensive literature on 
the role of complement in the prevention of the 
formation of immune complexes, and the dissolution of 
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such complexes once formed. (Reviewed by Schifferli et 
al. 1986, Whaley 1987). The probable mechanism of these 
effects has been summarized in Chapter 1. The emphasis 
of research in this area has been on immune complexes in 
vitro and in the circulation, and an effect on immune 
complexes trapped in the tissues has been largely 
overlooked. The single exception is a report by 
Bartolotti and Peters (1978) that the removal of 
glomerular antigen by rabbits with acute serum sickness 
is inhibited if complement is depleted by cobra venom 
factor. My findings confirm this result, and also 
indicate that although the effect of decomplementation 
is not immediate, after a few days the removal of 
antigen virtually ceases. ' This implies that either the 
activity of complement is the only important mechanism 
by which deposits are removed, or other mechanisms are 
dependent upon the activity of complement. Removal of 
complement was the only form of intervention attempted 
which produced an unequivocal effect on subepithelial as 
well as mesangial deposits. As with complex dissolution 
in vitro, this effect probably only requires activation 
of complement components up to C3; depletion of C5 was 
recently reported to have no effect on the morphology of 
a comparable form of glomerulonephritis, though 
'This delay suggests that it is complement already bound to the 
deposit which is having this effect, rather than complement in the 
circulation. 
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assessment of deposit load was only semi-quantitative 
"and C5 depletion was incomplete (Iida et al., 1987), 
The action of complement in glomerulonephritis has 
previously been viewed by most authors as exclusively 
deleterious, causing proteinuria probably largely by the 
action of the membrane attack complex on the basement 
membrane and podocytes (Biesecker 1983, Couser et al. 
1985, Perkinson et al. 1985). Proteinuria in the 
cationic BSA model studied here is also complement 
dependent, and complement is seen to be a 'two-edged 
sword': the rats given CVF during recovery had less 
severe'proteinuria despite having more antigen and 
larger deposits in 'their glomeruli than the control 
group. A recent publication in this area suggests 
further involvement of complement. 
-In a chronic serum 
sickness model in the mouse, Sawtell et al. (1988), found 
that animals-given CVF could produce subendothelial but 
not subepithelial deposits. 
- 
Mice with circulating C3 
produced subepithelial deposits, whether or not C5 was 
present. The authors suggest that complement is 
necessary for the dissociation of subendothelial immune 
complexes (probably formed in situ) prior to 
translocation across the basement membrane and re- 
assembly at the subepithelial site. If dissolution of 
deposits was the only effect of complement then one 
might hope that the therapeutic administration of an 
excess of C3 (perhaps produced by recombinant DNA 
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techniques) might be beneficial in human 
glomerulonephritis; but the other functions of 
complement make this hope unlikely to be fulfilled, even 
if such a reagent became available. 
Other constituents of plasma. There is little 
evidence to implicate any other normal constituent of 
plasma in the removal of deposits, and none was studied 
here. The effects of administration of proteases has 
been described in Chapter 3; the biological relevance of 
this remains in doubt, and the administration of 
protease inhibitors has been claimed to reduce 
glomerular damage but have no effect on the glomerular 
deposits (Jennette et al. 1987). C-reactive protein has 
recently been claimed to be involved in the elimination 
of DNA from the circulation (Robey et al. 1985); there 
is no evidence that C-reactive protein is involved in 
deposit removal. This question was not addressed in this 
thesis, but since an acute phase response would 
presumably have been induced by several of the 
manoeuvres employed, notably the administration of 
Freund's complete adjuvant, it is probably not relevant. 
Other soluble agents. The only attempt made in 
this thesis to influence deposit removal by the direct 
action of a foreign agent is described in Chapter 13, 
relating to the effect of charged molecules. The failure 
of high doses of polyethyleneimine to have a detectable 
effect supports the contention of Gauthier and Mannik 
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(1986) that electrical charge is not involved in the 
persistence of deposits beyond the first few hours after 
deposition. The apparent effect of heparin in enhancing 
the removal-of glomerular antigen remains difficult to 
explain. This was the only experiment where an effect on 
the glomerulus antigen load was not paralleled by a 
significant effect on the deposit volume fraction. The 
result might therefore be called into question, but it 
is supported by the finding of a significant decrease in 
the antigen content of whole renal cortex in the same 
group. Heparin is a heavily sulphated 
mucopolysaccharide. It is strongly anionic, a strong 
acid. Its biological effects are numerous and most are 
poorly understood. In addition to its anticoagulant 
properties it facilitates the breakdown of chylomicra by 
activation of lipoprotein lipase; an action of potential 
relevance to the nephrotic state but without obvious 
relevance to the removal of immune complexes. Heparin 
inhibits the aggregation of platelets and has a slight 
vasodilator effect (O'Reilly 1980). in vitro it inhibits 
the action of complement, but such an action in vivo 
would be expected to inhibit deposit removal rather than 
enhance it. The natural function of heparin is not 
known; it is limited in distribution to the mast cells 
and is absent in some species (e. g. the rabbit). However 
it has close structural homology with the heparan 
sulphate proteoglycan of the basement membrane; it is 
even more highly sulphated (Hovingh et al. 1986). This 
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implies a potential interaction between heparin, 'the 
basement membrane and the deposits. If this effect is 
genuine, its mechanism is unknown, but it could have 
therapeutic potential and is clearly worth further 
investigation. 
Haemodynamics. Hmmodynamic alterations are known 
to influence the localization of immune complexes in the 
glomerulus, and it seemed possible that the rate of 
delivery of components of the plasma might influence the 
rate of deposit removal. Attempts were made to influence 
glomerular haemodynamics by unilateral nephrectomy and 
modulation of salt and protein intake. The glomerular 
filtration rate was chosen to confirm that changes were 
being induced; this is easily measurable, though it is 
perhaps of more relevance to subepithelial deposits than 
mesangial ones. Unilateral nephrectomy produced the 
greatest rise in single kidney GFR, but none of the 
methods applied produced any detectable change in the 
rate of deposit removal. Of course, it remains a 
possibility that larger alterations might have an 
effect; to take the extreme case, a complete cessation 
of perfusion could be expected to stop antigen removal, 
but the use of unilateral nephrectomy did produce a 
considerable alteration in GFR without altering antigen 
removal. It therefore seems unlikely that the changes in 
GFR seen in response to physiological stimuli would have 
any effect. The possibility that an extreme fall in 
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perfusion and GFR caused by severe glomerulonephritis 
itself might inhibit antigen removal has not been 
addressed. 
The importance of one other potential barrier to 
access was investigated by the administration of 
puromycin aminonucleoside. This agent increased the 
permeability of the filtration barrier (Table 6) and 
therefore presumably improved access of macromolecules 
to the subepithelial deposits. The extent of this 
improvement was not quantified, but the absence of any 
detectable alteration in deposit or antigen removal 
suggests that the permeability of the glomerular 
basement membrane is not rate-limiting. 
It has already been stressed that the cell 
population available to degrade deposits depends on the 
location of the deposits. There is widespread belief 
that in the mesangium, cells of the macrophage lineage 
are responsible for removal of the deposits. The 
apparent importance of complement in the removal of the 
deposits does not disprove this, as complement might be 
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necessary for opsonization. l If this 'is so, one might 
expect mesangial deposits to be removed more rapidly 
than subepithelial ones, and this has been shown to be 
the case. The number and activity of glomerular 
macrophages increases in many forms- of 
glomerulonephritis. Macrophages have been seen having 
phagocytosed material resembling deposits in an acute 
passive serum sickness model (Striker et al. 1979), but 
there is evidence in the literature which casts doubt on 
the importance of macrophages in the removal of deposits 
which have become established in the glomerulus over a 
period of days or longer. Most notable is the failure of 
anti-macrophage serum to cause an increase in the amount 
of antigen left in the glomerulus (Lavelle et al. 1981, 
Holdsworth et al. 1981) although in these experiments 
the antiserum was administered to assess its effect on 
glomerular damage, and the protocols were not ideally 
suited to detect an effect on deposit removal. 
Stimulation of the mononuclear phagocyte system with 
Corynebacterium parvum (Barcelli et al. 1981) or, as 
reported here, with Freund's complete adjuvant, will 
diminish the glomerular antigen load if performed while 
antigen is still being deposited. If performed during 
recovery this effect is not seen, indicating that the 
stimulated phagocytes reduce the delivery of antigen to 
1Such a requirement would be strikingly at variance with the 
ability of macrophages to phagocytose immune complexes in other 
locations. 
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the glomerulus, but do not enhance its removal. The 
failure of PVA and puromycin to enhance removal also 
suggests that glomerular macrophages do not have an 
important role in this respect. I have seen no 
convincing morphological evidence of phagocytosis of 
deposits by macrophages in the electron microscopic 
studies described in this thesis; on the contrary, after 
two weeks without antigen administration the mesangial 
deposits often appear to be fragmenting, as if 
dissolving in situ (Fig. 47). Unfortunately it is 
difficult to prove the negative. It will be necessary to 
repeat studies of the type described here with complete 
elimination of glomerular macrophages. Suppression of 
macrophages by irradiation will probably not be 
appropriate because of concurrent immunosuppression and 
direct damage to the kidneys. Administration of anti- 
macrophage serum perhaps provides the best hope of 
achieving this goal, but the preparations available 
commercially are not cytotoxic and production of a 
suitable antiserum will be difficult. 
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Figure 47. A typical mesangial deposit after two weeks 
of recovery, showing irregular, fragmented outlines and 
variation in density. There is no evidence of 
phagocytosis. Compare this with the firm outlines of the 
smaller subepithelial deposits above the basement 
membrane. x 45,000 
In concentrating on the mesangial macrophages one 
should not forget the more numerous intrinsic mesangial 
cells. It does not seem likely that these cells are 
involved, but it is difficult to assess their role as 
there is no tool reliably to enhance, inhibit or measure 
this activity. These cells can be damaged by the 
administration of anti-Thy. l antibody (Bagchus et al. 
1986) but the structural changes induced are so massive 
as to render meaningless any data on this role of 
mesangial cells. 
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The discussion of degradation by cells has so far 
considered only cells in the mesangium. These are 
clearly irrelevant to the removal of subepithelial 
deposits, which are in a space where the only cell type 
is the podocyte, an epithelial cell not known to have 
any capacity to degrade immune complex deposits. One may 
nevertheless consider the possibility of involvement of 
these cells. Subepithelial deposits are invariably 
covered by a sheet of podocyte cytoplasm. The deposits 
appear to influence theýpodocytes, causing foot process 
effacement and in some circumstances synthesis of an 
excess of basement membrane material. Phagocytosis is 
not seen, but could the podocytes influence deposit 
removal at the surface? Rearrangement of immune 
complexes on the podocyte surface is seen in Heymann 
'nephritis (Kerjaschki & Farquhar 1983, Camussi et al. 
1985, Cybulski et al. 1988), but perhaps the persistence 
of the deposits in this model is evidence of the 
inability of the podocytes to remove them. The evidence 
presented here of the lack"of an effect of puromycin 
aminonucleoside, which appears to be toxic to podocytes, 
is also indirect evidence against their involvement. 
What then is the function of the complement receptor CR1 
on the surface of the podocytes (Gelfand et al. 1977, 
Shin et al. 1977, Burkholder et al. 1977)? It was 
originally suggested that its presence enhances the 
accumulation of subepithelial deposits by binding 
complement (Gelfand et al. 1977), but this detrimental 
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effect, even if, true, does not provide any biological 
justification for the synthesis of these receptors at 
this site. The importance of complement in removing 
subepithelial deposits and the known functions of other 
CR1-bearing cells in disposing of immune complexes 
suggests a similar role for podocytes, but is far from 
conclusive. CR1 also stimulates the degradation of the 
active forms C3b (Medof et al. 1982) and Cob (Medof et 
al. 1984), which might limit the destructive effects of 
complement activation at this site. The absence of CR1 
on the podocytes of laboratory animals (Moran et al. 
1977) suggests that its presence in man is perhaps not 
of vital importance, but CR1 has been reported to be 
present on human podocytes at a greater density than on 
any other cell type (Hogg et al. 
- 
1984), and the 
possibility that CR1 is induced in other species in the 
presence of immune complex disease does not appear to 
have been investigated. It would also be of considerable 
interest to measure the rate of breakdown of pre-formed 
immune complexes by cultured human podocytes in the 
presence or absence of complement. 
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CONCLUDING REMARKS 
This thesis has provided evidence that the immune 
complex deposits formed in the cationic BSA model of 
chronic serum sickness glomerulonephritis are removed 
mainly by a physico-chemical process of dissolution in 
situ., This process is largely dependent on the presence 
of complement but is inhibited by specific antibody, 
which is also essential for initial deposition. No 
evidence could be found of the direct involvement of any 
of the various'cell types of the glomerulus. Tentative 
evidence is offered that the administration of heparin 
enhances the removal of deposits; the mechanism of this 
effect is unclear. 
Further investigation is required to elucidate the 
role of complement and in particular the involvement of 
CR1 on the glomerular epithelial cells. It will be 
necessary to confirm the effect of heparin tentatively 
identified here and to investigate its mechanism. This 
work has also provided a format by which any existing or 
new therapeutic substance may be tested for an effect on 
deposit removal. An improved understanding of the 
mechanism by which deposits are removed provides a 
potential avenue of therapy for the numerous forms of 
human glomerulonephritis which do not at present respond 
adequately to treatment. 
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APPENDIX 1 
The difficulty of toxicity encountered in the 
preparation of the antigen has been described in 
Chapter 4. The published protocols (Hoare & Koshland 
1967, Border et al 1981,1982) in my hands resulted in a 
product with an extremely high pI (>11) which was toxic. 
The following protocol results in a more modest 
cationization, and a product with a pI which is usually 
between 8 and 10. 
All equipment was sterilized before use. 
100ml of water was added to 15m1 of ethylenediamine 
(Sigma) in a large beaker with stirring and cooled to 
25°C. Hydrochloric acid was added to pH 5.5 and the 
mixture cooled again to 25°C. 5g of BSA (dissolved in a 
minimum of water) and 0.5g of 1-ethyl-3(3-dimethyl- 
aminopropyl) carbodiimide (Sigma) was then added as a 
dry powder, with stirring. The reagents were maintained 
at pH 5.5 and 25°C for one hour, then the reaction was 
stopped by adding 30ml of 4M acetate buffer, pH 5.5. The 
liquid was passed through a 1.2µm filter into dialysis 
tubing and dialysed against distilled water for 48 hours 
at 4°C with frequent changes. Excess water was extracted 
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using'Aquacide III (Calbiochem) to a volume of about 
50m1. This concentrate was divided into vials (of known 
weight) for lyophilization and stored under vacuum at 
-20°C. - 
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APPENDIX 2 
The pI of each sample of cationic BSA was checked by 
isoelectric focussing on modified thin cellulose acetate 
membranes as described by Ambler & Walker (1979), with 
the assistance of Dr Ambler in the Department of 
Clinical Chemistry, University Hospital, Nottingham. 
Briefly, thin cellulose acetate membranes ('Cellogel', 
Whatman) were methylated by immersion in boron 
trifluoride in methanol. The modified membrane was 
soaked in a 50-80g/L solution of ampholines (pI 2-12; 
Serva) with 5% glycerol. It was placed in a Shandon 
electrophoresis tank with tap-water cooling and moist 
chamber, and run at 600V for 90 minutes. Samples (O. 5µ1) 
were applied 10 minutes after separation started, using 
a double wire applicator. After separation the membrane 
was fixed in 5% trichloracetic acid, washed and stained 
with Coomassie Blue R. A mixture of protein markers of 
known pI was included in each run to permit quantitation 
of the changes in pI. 
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APPENDIX 3 
The method is modified from that of Martin and Ames 
(1961). 
Preparation of, gradients 
250m1 of 37.5% sucrose in gelatin-veronal buffer was 
prepared and dilutions made as follows: 
Final strength (%) ml 35% sucrose ml buffer 
12.5 25 50 
18.5 37 38 
25 50 25 
31 62 13 
37.5 75 0 
The solutions were cooled to 4°C then 0.8m1 of each was 
layered by hand into Beckman polyallomer ultracentrifuge 
tubes, starting with the most dense. Equilibration was 
allowed to proceed for 1, hour then 100µl of the sample 
was layered on to the surface, followed by 300µ1 of 
liquid paraffin to minimize surface vibration. The tubes 
were spun for 6 hours at 4°C in a Sorvall OTD-65 
ultracentrifuge in an AH650 head. The bottom of each 
tube was then pierced and each sample collected into 17 
fractions for gamma counting. 
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APPENDIX 4 
Reagents 
1251: 74MBq, pH 7-11. (Amersham) 
Protein solution, 50mg/ml, in 0.05M phosphate buffer 
Sodium metabisulphite, 1.2mg/ml, in 0.05M phosphate 
buffer, pH7.2 
Potassium iodide solution, 1mg/ml, in 0.05M phosphate 
buffer, pH7.2 
Chloramine T solution, 5mg/ml, in 0.05M phosphate 
buffer, pH7.2 
Protocol 
20µl of 0.5M phosphate buffer, pH7.2 was added to the 
1251, mixed, and 20µ1 of protein solution was added 
followed by 2081 of Chloramine T. The reaction was 
allowed to proceed for two minutes. 200 µl of sodium 
metabisulphite solution was added to stop the reaction. 
Two minutes later, 620µ1 of potassium iodide solution 
and l00µ1 of protein solution was added, to make up to 1 
ml. 10µl was removed to subsequently assess labeling 
efficiency and the rest was dialysed against phosphate 
buffered saline for 24 hours. A further 10111 sample was 
removed. Both samples were counted, then the protein in 
these samples was precipitated with trichloracetic acid 
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and the precipitate was re-counted, permitting 
calculation of the efficiency and loss at dialysis. 
The labeled protein was added to sufficient unlabeled 
protein (at 100mg/ml in saline) to complete the 
experiment. It was mixed thoroughly and duplicate l0µ1 
samples were taken for counting to measure the specific 
activity in cpm/mg of the antigen as injected. The 
remainder was separated into aliquots and stored at 
-70°C until use. 
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APPENDIX 5 
Paraffin sections. Tissue samples were fixed in 10% 
buffered formalin, placed in TissueTek® cassettes and 
processed to paraffin wax in a TissueTek® VIP automatic 
tissue processor. Sections 511m thick were cut on a Leitz 
sledge microtome and stained conventionally with 
Haematoxylin and Eosin. 
. 
Frozen sections. Fresh tissue was mounted on cork 
discs in OCT embedding medium (TissueTek®) and frozen by 
immersion in freezing isopentane (-170°C). Samples were 
stored where necessary over liquid nitrogen. Sections 
were cut using a Slee cryostat. 
Sections were examined using a conventional Leitz SM Lux 
microscope. 
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APPENDIX 6 
Tissue samples were cut into cubes approximately lmm 
across and fixed for a minimum of 4 hours in 0.25% 
glutaraldehyde (TAAB) in 0.1M cacodylate buffer, pH7.4, 
adjusted to 300mOsm. with sucrose. They were then washed 
in buffer and post-fixed in 1% aqueous osmium tetroxide 
for 11/2 hours, dehydrated througl six grades of 
alcohol/water, infiltrated with EMIR® resin (EMSCOPE) 
and polymerized at 60°C for 16 hours. 
Preliminary'O. 5µm sections were cut with 25mm glass 
knives on a Reichert ultracut E ultramicrotome and 
stained on glass slides with 1% toluidine blue. After 
selection of an appropriate area the block was trimmed 
to size and 80nm sections were cut, mounted on 200 mesh 
copper grids, flattened with chloroform vapour and 
stained with uranyl acetate (Stempak & Ward 1964) and 
lead citrate (Reynolds 1963). The grids were examined in 
a JEOL 1200EX electron microscope at 80KV. Photographs 
were taken using Kodak 4489 electron microscope film and 
printed on Agfa Rapitone paper. 
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APPENDIX 7 
Plates were prepared by pouring 3.5m1 of 1% agarose in 
barbitone buffer pH 8.5 into 5cm diameter Petri dishes. 
After the gel had set, holes were punched 0.8cm apart, 
0.5cm in diameter, using a template and cutter. The 
wells created were filled with serum or antigen 
solutions and left in a moist chamber at room 
temperature overnight. The plates were viewed by dark 
ground illumination. 
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APPENDIX 8 
The dipping film technique was used throughout, with 
Ilford K5 emulsion. Sections were prepared on slides 
coated with chrome gelatin. Blank slides and slides 
bearing non-radioactive rat kidney were used as 
controls. 
Equipment 
Coplin jar 
50m1 measuring cylinder 
Glass stirring rod 
Slides (at least 6 from each block, in a plastic rack) 
Water bath & thermometer 
Sterile plastic forceps 
Light-proof boxes 
Silica gel bags (dry) 
Ice tray and cooling plate 
Paper tissues 
Protocol 
Glassware was cleaned in 5% chromic acid overnight, with 
thorough rinsing and a final rinse in distilled water. 
The water bath was pre-heated to 40°C, with the Coplin 
jar and measuring cylinder in, and 20ml of water in the 
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measuring cylinder. The sections were thoroughly dewaxed 
in xylene and graded alcohols, then allowed to dry. 
Under appropriate illumination, emulsion shreds (20m1) 
were added to the water in the measuring cylinder, 
stirred and poured into the Coplin jar. This was stirred 
gently for about 15 minutes in the dark, avoiding 
bubbles, until dipping a blank slide produced an even 
emulsion. The section slides were then dipped, allowed 
to drain for 30 seconds, wiped on the back and placed on 
the cold plate for 5 minutes to set. They were then 
placed in light-proof boxes with silica gel bags to dry 
at"4°C. The bags were changed after 24 hours, then left 
until developing. In each batch a small number of 
sections were fogged deliberately by exposure to light, 
as a control against negative chemography. 
Developing 
Slides were developed at intervals in Ilford Phenisol, 
diluted 1: 4 with distilled water, at 20°C for 5 minutes 
in the dark. They were transferred to a 0.5% acetic acid 
stop bath for 30 seconds, then to Ilford IF23 fixer, 
diluted to 30%, for twice the time taken to clear the 
slides (about 30 seconds). They were washed for 30 
minutes in distilled water, dried and stained lightly 
with Toluidine blue. 
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APPENDIX 9 
Urine samples were centrifuged to remove sediment. 0.5m1 
was mixed with 3.5m1 of 3% sulphosalicylic acid in a 
clean glass test tube, `and placed in a calibrated EEL 
nephelometer. If the reading was over 100 the sample was 
diluted and the test repeated. 
A calibration curve for this protocol was constructed by 
dilution of a sample of rat plasma of known total 
protein concentration, to provide a range of 0.01 to 1 
mg/ml. 
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APPENDIX 10 
Tissue was fixed using Karnovsky's fixative (5% 
glutaraldehyde, 20% paraformaldehyde) using the surface 
fixation method described in Chapter 6. After a minimum 
of 4-hours of fixation the superficial cortex was 
removed with a scalpel to a depth of approximately 
0.5mm, to expose surface fixed glomeruli. The sample was 
trimmed, washed in distilled water and dehydrated 
through graded alcohols with ultrasonication (Mettler 
electronics) to clean the surface. It was subjected to 
critical-, point drying under carbon dioxide using a 
Samdri pvt-3 and mounted on 1cm aluminium stubs using 
colloidal graphite in isopropanol (TAAB). After drying, 
this assembly was placed in a Balzers SCD 030 sputter 
coater and coated with gold in an atmosphere of argon. 
The samples were'examined in a JEOL JSM-35 scanning 
electron microscope at 20KV. Photographs were taken 
using Ilford Pan F 120 film and printed on Agfa Rapitone 
paper. 
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APPENDIX 11 
The assay was performed using Titertek 280µl flat- 
bottomed PVC microplates. 0.01M phosphate buffered 
saline, pH7.2, with 0.1% Tween was used unless specified 
otherwise. 
The wells were coated with BSA by soaking in 1% BSA in 
buffer for 1 hour. They were washed three times with 
buffer and allowed to dry. 
Serum samples were added, initially at a dilution of 
1: 1000,200µl per well and incubated at 37°C for 1 hour, 
washed three times and allowed to dry. 
Alkaline phosphatase-conjugated anti-rat IgG was 
purchased from Sigma and applied at a dilution of 1: 106, 
200µ1 per well, incubated at. 37°C for 1 hour, washed 
three times and allowed to dry. 
Alkaline phosphatase colour substrate (p-Nitrophenyl 
phosphate disodium; Sigma 104 phosphatase substrate) was 
added at a concentration of lmg/ml, 200µ1 per well, in 
carbonate buffer, pH 9.0. This was incubated until 
colour production was obvious (about 30 minutes). The 
reaction was stopped by adding 50µl of 3M sodium 
hydroxide to each well, and the colour was read in a 
Titertek multiscan plate reader. 
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If rat anti-BSA was present in the serum, the resultant 
'sandwich' is shown in Figure 1A. 
Figure 1A, 
Colour 
reagent F* Alkaline 
Phos hatase 7 
Anti-rat IgG 
Rat anti-BSA 
The results were recorded as arbitrary 'optical density' 
units, because a sample of rat anti-BSA of known 
concentration was not available for use as a standard. A 
single sample of serum with a high titre of anti-BSA 
antibody was diluted up to 20-fold and replicate assays 
performed. This confirmed the linearity of the assay 
over the range studied, justifying the comparison of 
readings between samples on a single plate. Controls 
included the use of non-immune rat serum and the 
omission of each of the reagent steps. 
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APPENDIX 12 
Isolation of a gamma globulin fraction by sal 
precipitation 
Aseptic precautions were observed as far as was 
practical. A saturated solution of ammonium sulphate was 
prepared by heating with stirring, then cooling 
overnight. The pH was adjusted to 7.2. This solution was 
added to the serum, drop by drop with vigorous stirring, 
to a concentration of 82m1 of ammonium sulphate to 100 
ml of serum. This was allowed to stand at room 
temperature overnight. The precipitate was washed twice 
in 45% saturated ammonium sulphate solution, then re- 
dissolved in a minimum volume of saline and dialysed for 
24 hours against distilled water at 4°C. The product was 
lyophilized and stored at 
-20°C. Reconstituted samples 
were passed through a 0.2µm filter before administration 
to animals. 
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APPENDIX 13. 
Hmmolytic plate assay for complement 
All solutions' were` prepared in complement fixation 
diluent (CFD: Flow laboratories). 
Sheep red blood cells were washed three times and a 10% 
suspension prepared. 2ml of this was mixed with 2m1 of a 
1: 500 dilution of rabbit haemolytic serum (Wellcome) and 
incubated at 4°C for 15 minutes. The cells were washed 
three more times and diluted to a 1% suspension. 
2% agarose was melted then cooled to 52°C in a water 
bath. The temperature of 4.5m1 of the sensitized cells 
was also raised to 52°C then mixed with 4.5m1 of the 
agarose. 3m1 aliquots were immediately poured into three 
level 5cm Petri dished and allowed to cool. Holes 0.3cm 
in diameter were cut using a template and cutter and the 
plates were stored at 4°C for a maximum of four days 
before use. 
Samples of serum were added to fill the wells. The 
plates were kept at 4°C overnight in a moist chamber to 
allow diffusion of complement components into the gel, 
then developed for 1 hour at 37°C. Each plate included 
at least one sample of normal rat serum as control. 
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APPENDIX 14 
200-300m1 of distilled water was brought to a vigorous 
boil, and 10ml of a 30% solution of ferric chloride was 
added rapidly. The resultant dark red liquid was cooled 
and dialysed for 24 hours against distilled water. 5ml 
of this stock solution was diluted before use with 9ml 
of distilled water and 6m1 of glacial acetic acid, 
resulting in a pH of about 1.8. 
The working solution was applied to de-waxed paraffin 
sections for 5 minutes, then washed in 5% acetic acid. 
The localization of the cationic colloidal iron was 
visualized by Perl's stain (2% potassium ferrocyanide). 
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APPENDIX 15 
This method was adapted from Schurer et al. (1978). All 
solutions were used at 4°C. 
Tissue was lightly fixed in 0.5% glutaraldehyde for 1 
hour, then washed in three changes of cacodylate buffer, 
pH 7.3. 
The samples were then immersed in a 0.5% solution of low 
molecular weight (1,800) polyethyleneimine (PEI) in 
saline, pH 7.3, for 30 minutes. Some of the animals 
described in Chapter 13 had already received systemic 
high molecular weight PEI (40,000-60,000); this step was 
omitted in these cases. 
The tissue was washed three times in buffer again then 
immersed in 2% phosphotungstic acid in cacodylate 
buffer, with the pH corrected to 7.3, for 1 hour. 
Washing was again performed three times and the tissue 
was processed routinely for transmission electron 
microscopy as described in Appendix 6, though the times 
in uranyl acetate and lead citrate were reduced to 
enhance the contrast of the PEI staining. 
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Appendix 16 
Determinatic 
51. x_ T'1TT11 
This method is essentially that described and 
characterized by Layzell & Miller (1975), who 
demonstrated a close correlation between the results 
gained by this method and the conventional inulin 
clearance technique. 51Cr-EDTA was obtained from 
Amersham. Rats were lightly anaesthetized (0.1ml Hypnorm® 
i. m. ) to facilitate an accurate intravenous injection of 
51Cr-EDTA (O. lml: lO. Ci, 740KBq). The time was noted and 
the animal weighed. After an accurately timed interval 
of about one hour the animal was heavily anesthetized 
(0.2m1 Hypnorm(D, 0.2m1 diazepam), the abdomen opened and 
a blood sample taken from the inferior vena cava into a 
heparinized tube. The usual procedure of tissue sampling 
was then performed as described in Chapter 7. 
The clearance of 51Cr-EDTA was then calculated using the 
formula derived by Layzell and Miller: 
C=V Ln (Po/Pt) /t 
where C= the clearance in ml/min 
V= the distribution volume of 51Cr-EDTA 
Po = the plasma concentration of isotope at 
time zero, assuming instant homogeneous 
mixing. This is calculated as Po = I/V, where 
I is the initial dose. 
Pt = the plasma concentration of isotope at 
time t, determined by direct measurement. 
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t= the time of. sampling in minutes. 
To gain an accurate absolute value of GFR the volume of 
distribution V should be determined experimentally, 
using V= I/Pstable, Where I is the initial dose and 
Astable is the steady-state concentration of isotope 
reached in rats with bilateral nephrectomy. As the aim 
of this study was to compare groups this experiment was 
not performed, but the figure of 25% of body weight was 
taken from the literature (24.3% ± 0.9%, Layzell & 
Miller 1975; 26.9% ± 1.7%, Bryan et al. 1972). The 
values of GFR obtained should therefore not be assumed 
to be 'correct', but any error applies equally to all 
groups and the data is adequate for comparison between 
groups. 
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